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1. SUMMARY 
The recent sequencing of entire eukaryotic genomes revealed a great number of open 
reading frames (ORFs), most of which potentially code for proteins of unknown 
function. Identifying interaction partners may facilitate the functional characterisation 
of unknown gene products. Moreover, large-scale approaches to identify protein 
interactions may be used to untangle the complete interaction network of all the gene 
products expressed in a given organism, the so-called interactome. Currently, the 
yeast two-hybrid system is the most widely used genetic assay for large-scale 
detection of protein – protein interactions and it has successfully been applied to map 
the interactome of several organisms. However, since interactions in this system are 
detected in the nuclear environment, it does not account for the particular biochemical 
requirements of extracellular and integral membrane proteins. 
 In the first part of this thesis, I describe a novel genetic growth selection 
system to detect interactions between extracellular and transmembrane proteins in a 
topologically extracellular compartment of Saccharomyces cerevisiae. In this system 
the proteins of interest are expressed as fusions to mutually complementing mutant 
derivatives of the yeast ER resident transmembrane receptor Ire1p. Interaction 
between the proteins of interest causes dimerisation of the Ire1p moieties allowing for 
complementation and activation of Ire1p. Active Ire1p in turn triggers a signalling 
cascade, which induces expression of selectable reporter genes in the nucleus and 
promotes growth under selective conditions. The feasibility of this system to monitor 
interactions between extracellular proteins was demonstrated by specific pairings of 
epitope and single-chain Fv (scFv) antibody fragments. 
 In part two, I describe the application of this system in a screening procedure 
to select scFv antibody fragments that specifically bind to human Interleukin-13 (hIL-
13). In a first round, hIL-13 binders were selected from a scFv-antibody library by 
yeast growth under selective conditions. In order to improve their binding affinity, 
parts of the scFv fragments obtained from the primary screening were randomised by 
homologous recombination in yeast and subjected to growth selection under increased 
selective conditions.  
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1. ZUSAMMENFASSUNG 
Die vollständige Sequenzierung eukaryotischer Genome in den vergangenen Jahren 
ermöglichte die Voraussage einer grossen Anzahl offener Leseraster, die 
möglicherweise für unbekannte Proteine mit noch nicht definierten Funktionen 
kodieren. Kenntnisse über Interaktionen zwischen bereits beschriebenen 
Genprodukten mit diesen unbekannten Proteinen, würde eine rasche Zuordnung ihrer 
Funktion in bestimmte zelluläre Prozesse ermöglichen und ihre weitere 
Charakterisierung erleichtern. Genetische Methoden, die Interaktionen zwischen 
tausenden von Proteinen detektieren können, werden im grossen Rahmen zur 
Kartierung des sogenannten Interaktomes, der Gesamtheit der Interaktionen zwischen 
allen Proteine, die in einem Organismus exprimiert sind, genutzt. Zur Zeit ist das 
„Yeast two-hybrid“ system, in welchem Proteinwechselwirkungen im Zellkern der 
Bäckerhefe Saccharomyces cerevisiae detektiert werden, das gebräuchlichste 
genetische System. Es wurde erfolgreich zur Kartierung des Interaktomes 
verschiedener Modellorganismen angewandt. Eine wichtige Limitation dieser 
Methode ist jedoch,  dass die Detektion der Proteininteraktionen im Zellkern den 
besonderen biochemischen Ansprüchen von extrazellulären und transmembranären 
Proteinen nicht gerecht wird. 
 In der vorliegenden Dissertation beschreibe ich ein neues genetisches Hefe-
Wachstumsselektionssystem zur Detektion von Proteininteraktionen, das den 
Anforderungen von extrazellulären und transmembranären Proteinen insofern gerecht 
wird, als dass die Detektion im topologisch extrazellulären endoplasmatischen 
Retikulum erfolgt. In diesem System werden die zu untersuchenden Testproteine als 
Fusionen an reziprok komplementierende, mutante Formen des ER-ständigen 
Rezeptorproteins Ire1p exprimiert. Eine Interaktion zwichen zwei Testproteinen führt 
so zur Dimerisierung der mutanten Ire1p Domänen und erlaubt Komplementation der 
Ire1p-Aktivität. Aktives Ire1p löst eine Signalkaskade aus, die im Zellkern zur 
Expression von Reportergenen führt, welche Wachstum unter selektiven Bedingungen 
ermöglichen. Die Anwendbarkeit dieses Systemes zur Detektion von Interaktionen 
zwischen extrazellulären Proteinen durch Wachstumsselektion wurde anhand von 
spezifischen Paarungen zwischen Epitop und „single-chain“ Fv  (scFv) 
Antikörperfragmenten gezeigt. 
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 Diese Methode wurde in der Folge angewandt, um in einer ersten 
Selektionsrunde aus einem Pool von scFv Fragmenten diejeningen zu selektionieren, 
die spezifisch an humanes Interleukin-13 (hIL-13) binden. Um die Bindungsaffinität 
dieser primären Binder zu verbessern wurden sie, durch homologe Rekombination in 
Hefezellen randomisiert und einer zweiten strengeren Wachstumsselektion 
unterworfen. 
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2. INTRODUCTION 
Vital processes such as adaptation to a given environment, reproduction and 
differentiation are controlled via communication between cells and cell 
compartments. Emitted communication signals (e.g. hormones) or environmental 
conditions (e.g. extracellular matrix composition) are in many cases sensed by a 
variety of specific cell surface receptors and transduced to the nucleus via signalling 
cascades that eventually activate specific subsets of genes in the nucleus. In order to 
integrate a multitude of concomitant signals into one expressional output, many 
signalling pathways cross talk with each other to build a complex signalling network. 
These signalling processes are controlled by protein – protein interactions, which are 
further regulated by protein modifications. Knowing interaction partners of a given 
gene product would thus facilitate the characterisation of gene functions in living 
organisms.  
 The recent sequencing of entire eukaryotic genomes revealed potential open 
reading frames (ORFs) and provided basic information for further characterization of 
all the gene products and their interaction partners expressed in a given organism or a 
cell type. A number of techniques have been described which allow studying protein 
interaction networks in large-scale procedures. These techniques may be grouped into 
two categories: i) biochemical approaches in which interactions between proteins are 
detected or analysed in vitro, for example cross-linking and co-purification (phage-
display or ribosomal-display also belong to this category since selection steps in this 
methods also occur in vitro), and ii) genetic approaches, of which the classical yeast-
two-hybrid is the most popular method to detect protein – protein interactions in vivo. 
Both biochemical and genetic approaches have important advantages as well as 
limitations and all of them are rather complimentary than substitutes for each other.  
2. 1. Biochemical approaches 
Conventional biochemical approaches such as cross-linking, co-immunoprecipitation 
and co-fractionation by chromatography have been used in the past to detect protein – 
protein interactions. One disadvantage of purely biochemical methods is that 
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interacting proteins often exist in low abundance in living cells and are therefore 
difficult to detect. In contrast, technologies such as phage-display, yeast-surface-
display and ribosomal-display allow controlled expression of the proteins of interest 
(POI) and have in common that very high numbers of clones, each expressing a 
distinct protein, can be screened in a short time for the ability of the POI to bind a 
certain target. As a rough comparison, billions of clones can be screened within one 
week with phage-display while only millions of clones can be screened in two to four 
weeks with yeast-two-hybrids 1. Since in surface-display as well as in ribosomal-
display selection of clones through binding to a target protein occurs in vitro, binding 
conditions can be modified and thus adjusted to the requirements of every given target 
protein. As an alternative to these in vitro screening methods, protein complexes 
formed in vivo can be purified from cell lysates in large scale. Subsequent 
determination of the complex members by mass spectrometry has been shown to be a 
very powerful tool to analyse the interactome of yeast 2. An important limitation of 
biochemical assays, however, is that target proteins or studied protein complexes must 
be purified. Depending on the features they bear, many proteins can be extremely 
difficult to purify. Multi-spanning transmembrane proteins, for example, contain up to 
seven hydrophobic transmembrane domains, which complicate their purification in a 
native conformation. Due to this reason, membrane-attached proteins have been 
highly underrepresented in such assays 2. Ex vivo detection of protein complexes may 
additionally result in the loss of detection of transient interactions. 
2. 2. Genetic approaches 
In contrast to biochemical methods, in genetic assays interactions among proteins can 
be studied in in vivo settings and in physiological environments, thus bypassing time-
consuming optimisation of conditions. The classical yeast-two-hybrid system is 
currently the most widely used genetic system to identify protein interactions. In this 
system the proteins of interest are fused to either one of two separated domains of a 
transcription factor, a DNA binding domain and a transcription activation domain. 
Reconstitution of the transcriptional activator by a particular protein - protein 
interaction in the nucleus results in expression of selectable reporter genes. 
Interactions are detected by growth selection or colorimetric assays, which are 
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amenable to fully automated robotics platforms. The yeast-two-hybrid has been used 
in several attempts to map the protein interactome in the bacteriophage T7 3, the 
bacterium Helicobater pylori 4, the yeast Saccharomyces cerevisiae 5,6 and in the 
metazoan nemathode Caenorhabditis elegans 7,8. Since interactions between two 
proteins are detected in the nucleus, studied proteins must enter this cell compartment. 
A large number of proteins however cannot be transported to the nucleus due to 
features such as secretory signals directing them to extracellular compartments or 
domains, which attach them to membranes such as transmembrane domains, 
myristoylation- and farnesylation signals or GPI anchoring signals. Thus, similarly to 
in vitro assays, membrane-attached proteins, which constitute about 40% of all yeast 
gene products 9, have been found to be underrepresented in large-scale two-hybrid 
screenings performed so far to record yeast protein – protein interactions 5,6 (for 
review see 10). In order to address this problem, several genetic systems to detect 
protein interactions in other cellular compartments than the nucleus have been 
developed and shall be described here. 
2. 2. 1. β-Galactosidase complementation 
Intracystronic complementation of two mutant forms of the bacterial enzyme β-
Galactosidase (β-Gal) is exploited to sense protein – protein interactions in this 
approach. Pairs of the inactive β-Gal deletion mutant forms Δω and Δα are able to 
complement one another in trans and assemble to an active enzyme. These two 
mutant derivatives, bearing only weak affinity to each other, are C-terminally fused to 
the proteins of interest. Dimerization of interacting partners drives dimerization of the 
mutant β-Gal moieties and leads to complementation of the enzymatic activity 11. The 
great advantage of this system is that β-Gal activity can be detected by the use of 
chromogenic substrates in situ and in every compartment of a cell. β-Gal 
complementation has been used to monitor EGF receptor chain dimerization upon 
treatment with a cognate ligand in live mammalian cells 12. A considerable limitation 
of this system, however, is that it is not amenable to large-scale growth selection 
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screenings in eukaryotic cells since β-Gal activity does not confer a significant growth 
advantage to such cells.  
As an alternative to this technology, fluorescence energy transfer (FRET) has 
been used to visualize protein interactions in situ 13. The limitation of this technology 
lies in the requirement that the fluorescing groups must be sufficiently close to each 
other to permit efficient energy transfer. 
2. 2. 2. Dihydrofolate reductase (DHFR) complementation  
Dihydrofolate reductase (DHFR) plays a central role in the one-carbon metabolism 
and is required for survival of prokaryotic as well as eukaryotic cells. E.coli DHFR is 
selectively inhibited by the anti-folate drug trimethoprim. In contrast, murine DHFR 
has a 12’000-fold lower affinity to this drug and is thus not inhibited at concentrations 
lethal to E.coli 14. Murine DHFR has been described as comprising two domains both 
making contact to the substrate 15. Pelletier et al. 16 have shown that these, 
catalytically inactive separated domains, when covalently linked to an interacting 
domain (the GCN4 leucine zipper) reassemble in a GCN4 leucine zipper-dependent 
manner to form an active enzyme. Reconstitution of murine DHFR activity in E.coli
rescues growth in media containing trimethoprim concentrations, which completely 
inhibit endogenous DHFR. It was shown that the GCN4 leucine zipper can be 
replaced by virtually any interacting pair of proteins including membrane protein 
receptors 16-19 and could thus, in principle, be applied for cDNA library screenings to 
identify protein – protein interactions. By the use of a fluorescein-conjugated 
substrate of DHFR protein interactions can be directly detected in situ in any cell 
compartment by fluorescence microscopy or subjected to further analysis by 
spectrometry or fluorescence activated cell sorting (FACS). However, until now, no 
genetic screening identifying novel protein interactions by the use of the DHFR 
complementation system has been published. 
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2. 2. 3. Use of G-protein fusions to detect interactions between membrane-
attached proteins 
This system exploits the well-described G-protein signalling pathway as a read-out. 
G-protein coupled receptor activation triggers a conformational change in the G-
protein α-subunit inducing exchange of GDP by GTP. Consequently Gα dissociates  
Figure 1. G-protein fusions to detect protein – protein interactions in yeast. In Sacharomyces cerevisiae binding 
of pheromones to their G-protein coupled receptors cause growth arrest. Upon pheromone binding, a 
conformational change in the receptor cytoplasmic tail, induces exchange of GDP through GTP in the α-subunit of 
the trimeric G-protein. Consequently GTP-α dissociates from the βγ-subunits until GTP is hydrolysed. Through a 
kinase-signalling cascade, the βγ-heterodimer causes cell cycle arrest and induces gene transcription, preparing the 
cell for mating. Interaction of a candidate gene product (cDNA), fused to Gγ, with a membrane-attached protein of 
interest (X) inhibits βγ interaction with its downstream effector, thus blocking βγ-signalling to cell cycle arrest. In 
this system, interaction of two proteins of interest permits growth in the presence of mating pheromones. 
from the G-protein βγ-subunits. Either Gα or Gβγ-subunits activate downstream 
effectors until GTP is hydrolysed. In yeast, pheromone stimulation leads to 
dissociation of GPA1 (Gα) from the STE4 (Gβ)/STE18 (Gγ)-subunits. Gβγ leads, 
through a kinase-signalling cascade, to cell cycle arrest, gene transcription, cell fusion 
and mating 20. In this system a protein of interest is solubly expressed in the cytosol as 
a fusion protein to Gγ, whereas an integral membrane protein of interest is expressed 
in its wild type conformation. Interaction between the Gγ-fusion with the integral 
membrane sequesters Gβγ and interrupts signalling to growth arrest and mating 21. As 
a consequence cells expressing interacting partners continue to grow in presence of 
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pheromone. In contrast to two-hybrid methods, in this system only one protein is 
required to be expressed as a fusion. In rare cases fusions may alter functional activity 
of a protein, although rather conformation than function is crucial for interaction 
screenings. A disadvantage compared to the membrane two-hybrid systems described 
below is that in this system one interacting partner must be expressed as a soluble 
cytosolic protein. Thus, G-protein fusions cannot detect interactions between two 
integral membrane proteins. Dohlman and colleagues have demonstrated the 
interaction between syntaxin 1 and neuronal Sec1 by applying the G-protein fusion 
system. In a subsequent screening they identified Sec1 mutants that are no longer able 
to bind syntaxin 1 21. 
2. 2. 4. SOS recruitment system (SRS) / Ras recruitment system (RRS) 
Both systems described in this section take advantage of the finding that some 
mammalian components of the ras-signalling pathway can substitute for their 
homologues in yeast. Ras is localised to the plasma membrane by a farnesyl moiety 
attached to a consensus sequence in its C-terminus. Ras on one hand is activated by 
guanyl nucleotide exchange factors (GEFs) and on the other hand negatively 
regulated by GTPase activating proteins (GAPs). Yeast cdc25 is a Ras specific GEF 
and exchanges GDP with GTP. Ras-GTP signalling, through andenylate cyclase, 
culminates in cell cycle progression. Consequently, the temperatur-sensitive cdc25-2 
strain is unable to grow at non-permissive temperature. If localised to the plasma 
membrane, hSOS the human homologue of cdc25, can complement for the 
temperature sensitive allele cdc25-2 to allow cell survival and proliferation 22. In the 
SOS recruitment system (SRS) hSOS localisation to the plasma membrane in a cdc25-
2 strain is mediated by interaction between two hybrid proteins of which one is fused 
to hSOS and the other one to a myristoylation signal that attaches it to the membrane. 
The SRS was successfully used to screen for negative regulators of c-Jun 23. In this 
set-up of the SRS a relatively high number of false positive clones were found to be 
mammalian Ras. Since yeast GAPs are unable to inhibit mammalian Ras, rare events 
of hSOS interactions with mammalian Ras are sufficient to rescue growth of cdc25-2 
at non-permissive temperature. Co-expression of mammalian GAPs however solved 
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this problem 24. An alternative approach termed Ras recruitment system (RRS) 
exploits the requirement of Ras localisation to the membrane for its function. 
Figure 2. SOS recruitment system (SRS) and Ras recruitment system (RRS). Cdc25, the yeast Ras guanyl 
nucleotide exchange factor (GEF) activates the Ras signalling cascade by exchanging GDP through GTP. GTPase 
activating proteins (GAPs) negatively regulate Ras signalling. In yeast GTP-Ras activates adenylate cyclase, which 
signals to cell cycle progression. Mammalian Ras pathway members can substitute for their homologues in yeast if 
recruited to the plasma membrane. Localisation of hSOS, the human homologue of cdc25, to the membrane 
rescues growth of a temperature sensitive cdc25-2 strain at nonpermissive temperature (37°C). In the SOS 
recruitment system (SRS) localization of hSOS to the membrane is mediated via protein interaction between a 
protein of interest (X) and a candidate gene product (cDNA). The Ras recruitment system (RRS), in contrast 
exploits the fact that Ras needs to localise to the plasma membrane to exert its function. A constitutively active 
mutant form of mouse Ras (mRas(61)ΔF) rescues growth at nonpermissive temperature in the same cdc25-2 strain 
if recruited to the membrane by protein – protein interaction.  
Instead of hSOS, a constitutively active mutant mammalian Ras lacking its 
farnesylation signal (mRas(61)ΔF) is recruited to the membrane by protein-protein 
interactions. In the same cdc25-2 background protein interaction mediated recruitment 
of mRas(61)ΔF to the membrane rescues growth at elevated temperature 25. This 
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strategy readily excludes false Ras-positives (since wild-type Ras, in cdc25-2 strains 
can no longer be activated) however, cannot exclude reconstitution of yeast Ras-
signalling by clones expressing hSOS (hSOS would complement cdc25-2 and activate 
the yeast endogenous Ras). Neither the SRS nor the RRS are amenable to detect 
interactions between two integral membrane protein since direct fusion of integral 
membrane proteins to hSOS in SRS or mRas(61)ΔF in RRS would constitutively 
activate Ras-signalling and rescue growth at elevated temperature independent of 
protein interaction. Recently the RRS was adapted to study dimerization-induced 
autophosphorylation of the kinase domain of the EGF receptor. In this set-up 
Ras(61)ΔF was expressed as a fusion protein to the phospho-tyrosine adaptor Grb2. 
Autophosphorylation of tyrosine residues in the EGFR C-terminus recruited the Grb2-
Ras fusion to the phospho-tyrosine and further activated Ras-signalling 26. It is, 
however, not apparent why the membrane-attached constitutively active Grb2-Ras in 
this approach, can be further activated by recruitment to phospho-tyrosines. 
Interactions between transmembrane proteins can be studied in a similar approach, 
where the proteins of interest are fused to the N-terminus of the mouse EGF receptor 
(mEGFR). Dimerisation-induced activation of the mEGFR kinase domain and 
subsequent cross-phosphorylation of the tyrosine residues recruits the Grb2-Ras, 
lacking a farnesylation or a myristoylation signal, to the membrane and rescues 
growth at elevated temperature (T. Gunde and A. Barberis, unpublished results). Until 
present such a modification of the RRS was not implicated for a genetic screening to 
identify integral membrane protein interactions. 
2. 2. 5. Mammalian protein – protein interaction trap (MAPPIT) 
In mammalian cells ligand-induced clustering of type I cytokine receptor subunits 
leads to phosphorylation of tyrosine residues in the C-terminus of the receptor chains 
by receptor-associated janus kinases (JAKs). Such modified phospho-tyrosines are 
recognised by signal transducers and activators of transcription (STATs), which upon 
binding to the receptor and subsequent phosphorylation by JAKs translocate to the 
nucleus where they bind to specific DNA motifs in the promoter region of their target 
genes such as rPAP1. Mutating three tyrosine residues in the C-terminus of the leptin 
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receptor (LR) to phenylalanin (LR-F3) uncouples downstream signalling from 
receptor chain dimerization 27. By the use of gp130 C-terminus (gp130ct), containing 
four STAT binding sites, Eyckerman et al. 27 showed that foreign STAT binding sites 
Figure 3. The mammalian protein – protein interaction trap (MAPPIT). A) Binding of leptin (L) to its receptor 
(LR) causes receptor clustering and subsequent phosphorylation of tyrosine residues in the cytosolic portion of the 
receptor chains by receptor-associated janus kinases (JAKs). Signal transducers and activators of transcription 
(STATs) bind to phospho-tyrosines by their SH2 domain. JAKs in turn phosphorylate STAT monomers, which 
upon receptor activation, form active complexes that enter the nucleus and activate transcription of target genes. B)
Point mutations exchanging the tyrosine residues in the C-terminus of the receptor chains by phenylalanine (Y→F) 
uncouple STAT signalling from receptor dimerization and JAK activity. Recruiting gp130ct that contains four 
intact STAT binding sites to receptor dimers can reconstitute STAT signalling and causes induction of 
transcription from a STAT target gene (rPAP1) promoter. In the MAPPIT system, interaction between protein X 
and a candidate gene product (cDNA) cause STAT induced expression of the puromycin resistance gene under the 
control of the rPAP1 gene promoter. This permits growth of mammalian cells in media containing puromycin.  
can reconstitute ligand induced STAT signalling in trans if recruited to the mutated 
LR-F3 receptor chains. Two interacting proteins, each C-terminally fused to either 
LR-F3 or gp130ct, mediated recruitment of gp130ct to the mutated LR in this system. 
Upon interaction of two proteins of interest, STAT-induced expression of a
puromycin resistance gene driven by the rPAP1 gene promoter allows selection of 
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clones that co-express interacting proteins by growth in puromycin containing media. 
In a cDNA screening using a retroviral gene transfer to attain expression from single 
integrants Eyckerman et al. identified the proteins CIS and SOCS-2 to be interaction 
partners of the phosphotyrosine 402-binding motif in the erythropoietin receptor. 
Thus, the authors demonstrated detection of a modification dependant protein – 
protein interaction, which would probably not have been identified in a comparable 
yeast-two-hybrid screening. 
In contrast to heterologous systems, mammalian protein interactions mediated 
by cofactors or protein-modifications, such as phosphorylation, may preferably be 
detected in this system. Contrary, genes expressed in mammalian cDNA libraries may 
more likely interfere with the endogenous STAT-signalling pathway and thus lead to 
false positives. Compared to the ease of handling yeast, a screening in mammalian 
cells remains much more laborious and time consuming. 
2. 2. 6. The split-ubiquitin system 
In the split-ubiquitin system, which has originally been proposed by Johnsson and 
Varshavsky 28, ubiquitin serves as sensor protein. Ubiquitin is a small protein, which 
is covalently linked to lysine residues of proteins in order to target them for 
degradation by the 26S proteasome. Prior to degradation of the target protein, the 
ubiquitin moieties are recycled upon liberation from the target by ubiquitin specific 
proteases (UBPs). UBPs cleave at the junction between ubiquitin and the attached 
target protein; right C-terminally to the last residue of ubiquitin (for review see 29). 
Ubiquitin consists of two globular domains joint by a short linker. Separated N-
terminal and C-terminal domains, termed Nub and Cub respectively, still reassemble 
and fold into a functional “split-ubiquitin”, which is recognized by UBPs as a 
substrate 28. Introduction of a point mutation (I13G) in Nub led to NubG. NubG and 
Cub do no longer reassemble spontaneously but fold into a functional split-ubiquitin if 
brought together. In the split-ubiquitin system proteins of interest are N-terminally 
fused to either NubG or Cub. Dimerization of the proteins of interest brings NubG 
and Cub into close proximity allowing reconstitution of split-ubiquitin and leads to 
UBP-conducted liberation of any effector protein fused to the C-terminus of Cub.  
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Figure 4. The split-ubiquitin system to detect protein interactions. A) Ubiquitin ligation to target proteins (T) tags 
them for degradation. Prior to target degradation ubiquitin is recycled by ubiquitin specific proteases (UBPs), 
which liberate ubiquitin from the target protein. Ubiquitin consists of two globular subunits joint by a short linker. 
Separated N-terminal and C-terminal domains, Nub and Cub, respectively, spontaneously reassemble to split-
ubiquitin that is still recognised by UBPs. B) NubG, a mutant derivative of Nub exhibits lower affinity to Cub. 
NubG and Cub do no longer spontaneously assemble to split-ubiquitin. Covalent linkage of interacting proteins (X 
and cDNA) to either NubG and Cub can drive reassembly of separated domains to split-ubiquitin. UBP cleavage 
results in liberation of a C-terminally fused effector protein (E) that induces a growth selectable phenotype. C) The 
split-ubiquitin method has been applied to detect interactions of integral membrane proteins with cytosolic 
components and with transmembrane proteins. 
Two effector systems have been described recently. In one a transcriptional 
activator acts as effector, which upon UBP cleavage translocates to the nucleus where  
it activates transcription of selectable reporter genes 30. In the second system a 
modified version of the URA3 gene product containing a degradation signal in its N-
Terminus is C-terminally fused to Cub. The orotidine 5’ decarboxylase, the URA3 
gene product (Ura3p), processes in an enzymatic reaction 5-Fluoro-orothic acid  
(5FOA) into a toxic product thus inhibiting growth on media containing 5FOA. 
Interaction caused UBP cleavage instead liberates Ura3p and thereby reveals its 
degradation signal. Thus, interaction of two proteins in this system leads to liberation 
and subsequent degradation of Ura3p allowing growth on 5FOA plates 31. Although 
the URA3 gene has been successfully used for counterselection procedures, its 
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application in large scale screenings in inconvenient due to the general high 
background of unspecific growth in the presence of 5FOA 32 and the laborious 
procedure of multiple replica plating that is necessary for this selection assay. 
The split-ubiquitin system has also been adapted to study and screen for 
interactions between membrane-attached proteins 33,34. Depending on the orientation 
of the proteins of interest in the membrane, NubG and Cub are fused either N-
terminally (in the case of type II transmembrane proteins) or C-terminally (type I) to 
the proteins of interest so that the ubiquitin moieties reside in the cytoplasm. 
2. 3. Screening for protein – protein interactions in a topologically 
extracellular compartment of yeast.  
The extracellular environment differs in many aspects from the intracellular milieu. 
Na+ and Ca2+ concentrations for example are generally higher in the extracellular 
space and the redox-potential is rather oxidizing to cysteine residues than reducing as 
it is in the cytosol. Proteins expressed on the cell surface or in a topologically 
extracellular compartment such as the endoplasmic reticulum (ER) or the Golgi 
apparatus, are adapted to prevalent conditions and additionally subjected to specific 
post-translational modifications that influence their biophysical properties. For 
instance N-linked protein glycosylation in the secretory pathway can modify protein 
stability and binding affinities of extracellular interaction partners 35,36. Importantly, in 
the oxidizing environment of extracellular compartments cysteine residues can be 
covalently linked to each other through so called disulfide-bonds, which are in many 
cases required for proper protein folding and sustained protein stability 37. 
Considering their importance in cell regulatory mechanisms identifying interactions 
among extracellular proteins is of great interest. Due to the following reasons genetic 
systems detecting protein – protein interactions in the nucleus or in the cytosol may, 
however, not be adequate to detect extracellular protein interactions: i) Interactions 
between some cell surface receptors, e.g. integrins, and their ligands depend on 
extracellular concentrations of cations 38, ii) disulfide bonds cannot form in the 
oxidizing environment of the cytosol 39 and cytosolic expression of extracellular and 
transmembrane proteins may thus lead to misfolding and aggregation, and iii) 
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complex conformational binding domains of multi-spanning transmembrane proteins 
are unlike to be reconstituted in the cytosol. 
We thus developed a novel yeast cell growth selection system, which allows 
detection of protein – protein interactions occurring in the topologically extracellular 
environment of the ER. In this system we employed components of the yeast unfolded 
protein response (UPR) as sensory elements for protein interactions. 
2. 3. 1. The yeast unfolded protein response (UPR) 
In eukaryotic cells accumulation of unfolded proteins in the ER triggers a stress 
response, which culminates in expression of stress genes, such as the ER-resident 
chaperone Kar2p/BIP. In contrast to higher eukaryotes, where at least three pathways 
contribute to UPR signalling, 40 in yeast the type I transmembrane protein Ire1p is the 
only described receptor to sense accumulation of unfolded proteins in the ER lumen. 
Transduction of the stress signal to the nucleus in yeast is carried out by the 
transcriptional activator Hac1p 41,42. Ire1p comprises an N-terminal lumenal domain 
(NLD) possessing dimerization activity, a transmembrane domain (TM) and a 
cytosolic portion, which contains an intrinsic serine/threonine kinase as well as an 
endoribonuclease in its very C-terminus 43-46. At non-stress conditions the chaperone 
BIP associates to the NLD and hinders Ire1p homo-dimerization. In case of UP-stress 
BIP preferably binds to unfolded proteins to assist their refolding and by this is 
titrated away from the Ire1p-NLD 47. The now liberated NLD homo-dimerises and 
brings the cytosolic portions of Ire1p monomers into close proximity, activating the 
intrinsic kinase. Cross-phosphorylation subsequently activates the endoribunuclease 
located in the Ire1p C-terminus, which in concert with tRNA ligase removes a 252-
nucleotide intron of HAC1u mRNA (“u” for UPR uninduced) to produce the HAC1i
mRNA (“i” for UPR induced) 41,42,44,48-50. This unconventional splicing reaction 
results in a frame shift in the HAC1 mRNA open reading frame. Translation of the 
HAC1i mRNA results in the functional transcription factor Hac1p, which, upon 
activation of the UPR signalling cascade, binds to unfolded protein response element 
(UPREs) in the promoter region of stress genes and thereby activates their 
transcription 41,42,51. Unfolded or aggregated proteins that accumulate in the ER are 
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exported to the cytosol and degraded by components of the ER-associated degradation 
pathway (ERAD). UPR signalling activates transcription of ERAD genes such as 
DER1, HRD1, HRD3 or PER100 52,53. 
 UPR mutant cells (Δire1 or Δhac1) are inositol auxotroph and exhibit an 
increased sensitivity to UP stress inducing agents (such as tunicamycin, DTT) and 
elevated temperature 45,46. Deletion of ERAD genes causes constitutive activation of 
UPR signalling, which indicates cooperation between UPR and ERAD to overcome 
unfolded protein stress. Combined mutations in both, the ERAD and the UPR, cause 
synthetic lethality at nonpermissive temperature 52. 
2. 3. 2. SCINEX-P (Screening for interactions between extracellular proteins) 
Two mutually complementing mutant derivatives of Ire1p act a sensor for protein 
interaction in this system. Ire1K702R contains a point mutation in the kinase domain, 
which reduces its signalling potential upon dimerisation to about 40% 46. Ire1Δtail 
bears a C-terminal deletion for its last 133 amino acids, which completely abolishes 
its signalling activity 50. Upon hetero-dimer formation, these mutant forms of Ire1p 
complement each other to attain nearly 100% UPR signalling activity 50. The test 
proteins in this system are fused to either one of the Ire1p mutants such as to 
substitute for their NLD. Interaction between the proteins of interest brings the mutant 
Ire1p moieties into close proximity, which allows mutual complementation and 
reconstitution of the UPR signalling cascade. In order to generate an UPR reporter 
strain, we knocked out DER1 and/or IRE1, which are components of the yeast ERAD 
and UPR, respectively. In addition we stably integrated a reporter gene construct 
consisting of the two divergently oriented HIS3 and lacZ reporter genes under the 
control of a synthetic bi-directional promoter that contains one, two or three UPREs. 
In these knockout strains, dimerisation causes reconstitution of Ire1p activity and 
subsequent Hac1p production. As a consequence, three independently selectable read-
out systems are activated allowing growth under conditions that are selective for i) 
inositol synthesis, ii) resistance to higher temperature and iii) Hac1p dependent 
reporter gene expression 54. By applying conditions selective for different 
combinations of these three read-outs, the stringency of growth selection can be 
modulated. The feasibility of this system to monitor extracellular protein - protein 
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Figure 5. Screening for interactions between extracellular proteins; SCINEX-P and its potential applications. In 
this system interaction of two proteins of interest (X and cDNA) is detected via induced complementation of two 
mutant derivatives of Ire1p (Ire1K702R and Ire1Δtail). Upon dimerization of the mutant Ire1p moieties Ire1Δtail 
phosphorylates the kinase mutant Ire1K702R and by this activates its intrinsic RNAse activity, which in concert 
with tRNA ligase removes an intron in the Hac1u mRNA. Translation of the processed Hac1i mRNA produces the 
transcriptional activator Hac1p. Hac1p in turn binds to unfolded protein response elements (UPREs) in the 
promoter region of endogenous stress genes and integrated selectable reporter genes (lacZ/HIS3), which promote 
(or inhibit) growth under selective conditions. Induced expression of endogenous genes by Hac1p suppresses the 
temperature sensitive phenotype of Δire1 cells. Besides this Hac1p production is important for inositol synthesis. 
A) Detection of interaction between two extracellular proteins in the topologically extracellular lumen of the ER. 
The proteins of interest are fused to Ire1p N-terminally of its transmembrane domain. B) Integral membrane 
proteins can be expressed as full-length proteins fused to the cytoplasmic portion of Ire1p. C) Expression of a 
soluble ligand into the ER causes receptor chain dimerisation and complementation of C-terminally fused mutant 
Ire1p derivatives.
interactions and to select for specific interactions by growth was demonstrated with 
specific antigen – antibody pairings in the lumen of the yeast endoplasmic reticulum 
54
. SCINEX-P was then used, in two consecutive screenings rounds, to select scFv 
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antibody fragments that specifically bind to human Interleukin-13 (hIL-13). In the 
first screening scFv fragments specifically binding to hIL-13 were selected from a 
scFv-library. In the second round, binders obtained in the first screening were further 
randomised by homologous recombination in yeast cells, which were then subjected 
to screening conditions of higher stringency, allowing selection of binders with 
improved binding activity (chapter 3. 2. of this thesis).  
Table 1. Summary of genetic systems to detect protein - protein interactions outside the nucleus
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Advantages Limitations false positives References 
β-Gal complementation y/y y/y y/n n n Sensor protein activity (β-Gal) is not restricted 
to a particular cellular compartment. In vivo 
visualisation of β-Gal activity. 
Not amenable for growth selection.   11,12
DHFR complementation y/y y/y y/n y n Sensor protein activity (DHFR) is not restricted 
to a particular cellular compartment. In vivo 
visualisation of DHFR activity. FACS 
compatible. 
Growth selection only if DHFR is localized to 
the cytoplasm.  
14-19
SRS y/y (y)1/n n y y Detection of protein interactions outside the 
nucleus 
Not suitable to screen for interaction partners 
of membrane attached protein. No reporter 
gene activity for signal quantitation. 
Mammalian Ras and 
SOS in cDNA libraries. 
22-24
RRS y/y (y)1/n y/n y y Detection of protein interactions outside the 
nucleus 
Not suitable to screen for interaction partners 
of membrane attached proteins. No reporter 
gene activity for signal quantitation. 
Mammalian SOS in 
cDNA libraries. 
25,26
G-protein fusions y/y (y)1/n n y y Only one of the interacting proteins must be 
expressed as a fusion protein. 
Prey must be solubly expressed in the 
cytoplasm. 
not reported. 20,21
MAPPIT y/y (y)1/n y/n y y Mammalian proteins can be expressed in their 
cognate enviroment. Higher probability to 
detect modification dependent protein 
interactions. 
Prey must be solubly expressed in the 
cytoplasm. 
not reported. 27
Split ubiquitin 
  Transcriptional read-out
y/y y/y y/(n)1 y y Allows detection of interaction between two 
integral membrane proteins. 
One interacting protein must be membrane 
attached. 
Ubiquitin expressing 
clones. 
28-30,33,34
Split ubiquitin
  Ura3p enzymatic read-out
y/y y/y y/(n)1 y y Allows detection of interactions between 
cytosolic and/or integral membrane proteins. 
Allows positive and negative selection (on 
5FOA or on media lacking uracil, respectively).
No reporter gene activity for signal 
quantitation. Laborious and expensive growth 
selection on 5FOA. 
Ubiquitin expressing 
clones and URA3 
mutants. 
28,29,31
SCINEX-P y/y y/n y/y y (y)2 Allows detection of interactions between 
cytosolic, integral membrane and/or 
extracellular proteins. Stringency of growth 
selection can be modified by combinatorial use 
of the three selective read-out systems. 
Proteins with homo-dimerisation activity 
should not be expressed as fusions to 
Ire1K702R, due to its residual activity. 
Proteins with homo-
dimerisation activity if 
cDNA library is fused to 
Ire1K702R. 
54
y = yes; (y)1= yes but only one of the proteins of interest can be expressed as membrane attached proteins; (y)2 = manuscript submitted; n = no; (n)1 = need further adaptation; β-Gal = β-Galactosidase; DHFR = 
dihydrofolate reductase; FACS = fluorescence activated cell sorter; 5FOA = 5-fluoro-orothic acid. 
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3. RESULTS 
3. 1. Part I: Cell growth selection system to detect extracellular and 
transmembrane protein interactions 
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3. 2. 1. Summary
Single-chain antibody fragments (scFv) binding to full length mature cytokine 
Interleukin-13 (IL-13) were selected in vivo by using the yeast growth selection 
system SCINEX-P (screening for interactions between extracellular proteins) 1. In this 
system, scFv fragments and human IL-13 are expressed in the topologically 
extracellular lumen of the endoplasmic reticulum (ER), where, due to oxidizing 
conditions, disulfide bonds can form. Interaction between antigen and antibody, both 
fused to either one of two complementing derivatives of the dimerization-activated 
receptor Ire1p, induces signalling to the nucleus and thereby expression of selectable 
reporter genes. In a primary screening, binders against IL-13 were selected from an 
scFv-library containing 7 randomised amino acid residues in the complementarity-
determining region 3 (CDR3) of their heavy chain. The CDR3 of the light chain of 
these selected binders were subsequently randomised by homologous recombination 
in vivo. The resulting libraries were screened under increased selective pressure to 
identify binders with improved binding affinity. ScFv fragments obtained with this 
method specifically bind to human IL-13 in western blot assays and ELISA.    
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3. 2. 2. Introduction
The availability of entire eukaryotic genome sequences has fuelled endeavours to 
untangle the complex network of interactions between the gene products of a given 
organism. Identifying physical interactions of newly discovered gene products with 
known proteins facilitates their functional characterization. Traditional biochemical 
methods such as co-immunoprecipitation or cross-linking need laborious and time 
consuming optimisation of conditions for every pair of proteins and are thus not 
amenable to high throughput applications. For this reason, genetic systems such as the 
yeast-two-hybrid technology 2, which allows detection of protein – protein 
interactions in vivo and has been shown to be suitable for high-throughput screenings, 
have become very popular. However, conventional two-hybrid systems have evident 
limitations. For example, although roughly 40 percent of all proteins are anchored to 
the membrane 3 extracellular and membrane-attached proteins are significantly under-
represented in large-scale yeast two-hybrid screens performed so far 4-8. This indicates 
that conventional nuclear yeast-two-hybrid systems are not adequate for every class of 
proteins.  Several genetic systems have been developed to study protein – protein 
interactions outside the nucleus such as the Split-ubiquitin system 9, a G-protein 
coupled system 10, the SOS recruitment system 11, the β-Gal complementation 12 and 
DHFR complementation system 13 and, in order to circumvent the poor performance 
of transmembrane and extracellular proteins in the cytoplasm, some have successfully 
been adapted to study and screen for interactions among integral membrane proteins 
12,14-17,43
.  However, to our knowledge, none of these methods have been adapted to 
screen for extracellular protein interactions. Many extracellular proteins differ from 
intracellular proteins in that they are N-glycosylated and contain disulfide-bonds, 
which, for their formation, require an oxidising environment and cannot form in the 
reducing milieu of the cytoplasm or the nucleus. Other high-throughput methods, in 
which oxidising conditions can be reconstituted, such as phage-display 18 and 
ribosomal-display 19, rely on protein purification. This requirement is a considerable 
disadvantage regarding proteins that contain transmembrane domains or disulfide-
bonds, since these features complicate recombinant expression and purification. In 
general, methods that require protein purification show clear limitations regarding the 
analysis of transmembrane proteins. For example in a recent systematic analysis in 
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which yeast protein complexes have been purified and subsequently analysed by mass 
spectrometry, only 1% of identified complex members were membrane proteins 20. 
 We recently published a yeast growth selection method to identify interactions 
between transmembrane and extracellular proteins or protein domains in vivo 1. In the 
method termed SCINEX-P (screening for interactions between extracellular proteins), 
we employed components of the yeast endogenous unfolded protein response (UPR) 
to detect interactions between extracellular proteins in the topologically extracellular 
milieu of the ER lumen. In the wild-type situation, the type I transmembrane receptor 
Ire1p is localised to the ER membrane where it senses accumulation of unfolded 
proteins 21-23. If proper folding of proteins is impaired, dimerization of Ire1p is 
induced. Ire1p dimerization activates the UPR signalling cascade, which, through 
induced expression of the transcriptional activator Hac1p, signals to the nucleus 24-26. 
Expression of UP-stress genes induced by Hac1p confers tolerance to stress 
conditions such as elevated temperature 27. In addition, Hac1p is required for inositol 
synthesis 28. In our system the divergently oriented reporter genes lacZ and HIS3 that 
are under the control of a Hac1p inducible promoter, are integrated in a Δire1 yeast 
strain. The proteins of interest are fused to mutually complementing mutant 
derivatives of Ire1p 29,30 such as to substitute for the Ire1p ER-lumenal domain. 
Dimerization of two interacting partners in the ER lumen brings the mutant Ire1p 
moieties into close proximity, thus allowing complementation and UPR signalling. 
This permits growth under conditions that are selective for inositol synthesis, 
resistance to higher temperature and Hac1p reporter gene expression 1.  
 In the study presented here we demonstrate the suitability of the 
SCINEX-P system for screening purposes. As a model system we have chosen the 
interaction of an antibody fragment with an extracellular protein, the Interleukin-13. 
Both the scFv and Il-13 contain disulfide bridges, which are essential for their proper 
folding. The mature hIL-13 is a secreted 14kD four-helix bundle cytokine that 
contains four potential N-glycosylation sites and two intramolecular disulfide bridges. 
hIL-13 is a critical Th2-type cytokine and has been associated with immune defence 
against parasites via induction of IgE secretion and production of eosinophila. In the 
asthmatic lung however IL-13 seems to be the crucial cytokine to cause mucus 
hypersecretion and airway hyper responsiveness (AHR) (for review see 31), thus 
representing an interesting target for asthma therapy. We selected scFv fragments that 
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specifically bind to hIL-13. Two consecutive rounds of CDR randomisation directly 
in yeast, using the SCINEX-P screening technology, identified such scFv fragments. 
Thus, the SCINEX-P screening system was successfully used for identification of 
specific interactions between two extracellular proteins. 
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3. 2. 3. Experimental procedures
Yeast strains 
The S. cerevisiae strains IKU1-3 and IKU3-3 are of the following genotype: leu2-3, -
112; his3-11, -15::lacZ-1xUPRE-HIS3+; trp1-1; ura3-1; ade2-1; can1-100; MTA1a, 
and leu2-3, -112; his3-11, -15::lacZ-3xUPRE-HIS3+; trp1-1; ura3-1; ade2-1; can1-
100; MTA1a, respectively. Generation of these strains was described earlier 1.  
 Recombinant plasmids 
Ire1p fusion constructs were expressed from yeast Ars/Cen expression vectors of the 
origin YCpLac22 and YCplac33.  In the EcoRI- and SphI-treated vector YCplac33 
the EcoRI/SphI fragment from pDU12 1 was ligated so as to bring in the actin gene 
promoter (PACT1) and the GAL11 terminator flanking the MCS (containing the 
unique sites XbaI, XhoI, StuI, NotI and SalI) resulting in pDU13. In the XbaI-treated 
pDU13 a double-stranded DNA oligonucleotide coding for the SUC2 signal sequence 
(aa1-19) (S2ss) was ligated such that the 5’ XbaI site was destroyed while the 3’ XbaI 
site was reconstituted. In the resulting vector the C-terminally truncated Ire1p 
derivative Ire1Δtail495-982 (extending from residue 495 to 982) (described in 1) was 
ligated such as to substitute for the NotI/SalI fragment resulting in the “bait vector”. 
Human IL-13, extending from amino acid 35 to 146, was amplified by PCR from a 
human mixed tissue library (Clonetech) with primers providing a 5’ XbaI site and a 3’ 
NotI site, allowing in frame cloning of hIL-13 into the XbaI- and NotI-treated “bait 
vector” resulting in a fusion of the S2ss, the adjacent hIL-1335-146 and the Ire1Δtail495-
982
, in pDU172. The linkers containing the restriction sites were of the following 
sequence; S2ss-GCA TCT AGA GGC- hIL-1335-146-AAC AGC GGC CGC AAG- 
Ire1Δtail495-982 (XbaI and NotI restriction sites underlined. The last codon of the 
preceding and the first codon of the adjacent gene are in bold letters). The library 
vector was constructed on the basis of pMH30 1, a vector of the YCplac22 origin, 
containing the IRE1 gene promoter and the same MCS as pDU12. pMH30 was treated 
with XbaI and SalI, and the released XbaI/SalI fragment was replaced by a fusion of 
the following three fragments in a four-way ligation: i) a double-stranded DNA 
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oligonucleotide coding for the S2ss flanked by a 5’ XbaI site and a 3’ SfiI site, ii) a 
scFv antibody framework of the type λ7 VH1 linked by a 20-mer linker 
(GGGGSGGGGSGGGGSSGGGS). This framework flanked by distinct SfiI sites 
allowing directional cloning, was subcloned from pLib1 and iii) the Ire1p derivative 
Ire1K702R526-1115. The linkers containing the restriction sites were of the following 
sequence; S2ss-GCA TCG GCC CAG CCG GCC ATG-scFv-TCG GCC TCG GGG 
GCC TCT- Ire1K702R526-1115 (SfiI restriction sites underlined. The last codon of the 
preceding and the first codon of the adjacent gene are in bold letters). The 
Ire1K702R526-1115 (bearing a point mutation in the kinase domain and extending from 
amino acid residue 526 to 1115) was amplified by PCR as described in earlier 
publication 1 with a 5’ primer containing an SfiI site matching to the 3’ SfiI site of the 
scFv fragment, and a 3’ primer flanked by a SalI site. The resulting library vector was 
termed pDU162. The sequences of all the constructs used in this study were verified 
by Sequencing. 
 Making of the libraries 
In order to obtain the primary scFv library an existing library was subcloned into the 
SfiI-treated pDU162. The original library on the basis of a Vλ3- VH1 scFv fragment 
termed FW7.3 32, in which the 7 amino acid residues H97, H99, H100, H100A, 
H100B, H100C and H100D (according to Kabat numbering scheme 33) of the 15 
amino acids comprising CDRH3, have been randomised, had an estimated complexity 
of ~1 x 107 independent clones. Upon subcloning of this library into pDU162 and 
subsequent transformation into E.coli (KC8) about 7.5 x 106 colony forming units 
(cfus) were obtained. For the affinity maturation screening, the binders from the 
primary screening, S1-5 and S1-18, were prepared by introducing a second Acc65I 
site right behind the CDRL3 in addition to the existing Acc65I site directly upstream 
of the CDRL3. Cleavage with Acc65I removed the CDRL3. Treatment of the 
linearised vector with Klenow polymerase and subsequent religation of the vector led 
to the formation of a novel SnaBI site in the resulting CDRL3 deleted vectors. A 
donor DNA was synthesized by PCR using pDU162 as a template. The 3’ primer 
contained randomised codons for amino acid residues L93, L94, L95 and L95A 
(Kabat numbering scheme) in the CDRL3. The resulting PCR product started 42 bp 
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upstream and ended 42 bp downstream of the CDRL3, thus providing 5’/3’-flanking 
homology to the vector. The linearised vectors where co-transformed together with 
the double-stranded donor DNA into the reporter strain IKU3-3 where homologous 
recombination occurred in vivo. Homologous recombination between the linear vector 
and the donor DNA substituted the previously removed CDRL3 by the randomised 
CDRL3 from the donor DNA and re-circulated the vector. Randomised codons in the 
primer were of the sequence 5’-nnk nnk nnk nnk-3’, thus reducing the 
probability for stop codons from p = 0.047 to p = 0.031. As a consequence of this 
strategy the amino acid methionine was over-represented, whereas isoleucine was 
under-represented.   
Growth selection and media 
The competent S. cerevisiae strains IKU1-3 and IKU3-3 were pre-transformed with 
the “bait” construct prior to library transformation. In the primary screening, cells 
transformed with the library plasmid were directly plated on selective plates 
containing synthetic complete medium 34 lacking uracil, histidine, leucine and inositol 
(SC -U/H/L/Ino) and containing 30mM 3-amino 1, 2, 4-triazol (3AT), incubated at 
30°C for 2 days and then shifted to 37°C for additional 2 days. In the affinity 
maturation screening in contrast, transformed cells were first recovered in liquid SC- 
Ino at 30°C for 2 hours, washed in dH2O, re-suspended and plated on SC -U/H/L/Ino 
plates containing 30mM 3AT. Screening plates were immediately incubated at 37°C. 
In both screening upcoming colonies were re-streaked on SC -U/H/L/Ino + 30mM 
3AT plates and incubated at either 30°C (primary screening) or 37°C (affinity 
maturation screening). Screening positives were selected for loss of bait plasmids by 
growth on SC plates containing 50μg/ml uracil and 1mg/ml 5-Fluoro-orothic acid 
(5FOA) at 30°C. Subsequent replica plating or filter lifting on X-Gal plates 
(0.2mg/ml) revealed bait-dependency.  SC medium lacking inositol was prepared with 
inositol free yeast nitrogen base (Q-BIOgene). 
Assay of cellular β-Galactosidase activity 
β-Galactosidase activity of cells was determined using the protocol described in 34
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Protein expression and purification 
In vitro analysis of the different scFv fragments was performed with purified proteins, 
expressed in bacteria. The screening derived scFv fragments S1-5, S1-18, S2-13, S2-
14, S2-22 and S2-24 were cloned into the expression vector pAK400, providing a C-
terminal His6-tag, and were periplasmically expressed in E.coli JM83 (λ-, ara, Δ(lac, 
proAB), rpsL, thi, Φ80, dlacZΔM15) at 25°C. Periplasmically expressed scFv 
fragments were purified by immobilized metal ion affinity chromatography (making 
use of the C-terminal His6-tag). Fractions were analysed by SDS gel-electrophoresis 
on a 15% polyacrylamid gel. Purified proteins were  concentrated on MicroconR YM-
10 columns (Millipore). 
 In vitro analysis 
ELISA: 96 well plates (Nunclone maxisorb) were coated overnight with 2.5 μg/ml 
recombinant human IL-13 (research diagnostics inc. RDI) in TBS and subsequently 
blocked with TBST containing 5% milk. Purified scFv fragments were added to the 
wells at 5, 10 and 25 μM concentrations. Binding of the different scFv fragments to 
hIL-13 was detected with a secondary mouse anti-His6 antibody (QIAGEN) (diluted 
1:500) and a tertiary goat anti-mouse IgG antibody conjugated to horseradish 
peroxidase (HRP) (Santa Cruz Biotechnology) (1:4000). Signal detection occurred via 
measuring HRP activity using the “BM blue POD Substrate” (Roche) and measuring 
the optical density at λ=450 nm. Immunoblotting: 0, 4.5, 45 and 450ng recombinant 
human IL-13 (RDI) and 450 ng purified BSA (New England Biolabs NEB) were 
loaded in quadruplets on a SDS-15% PAGE gel and electroblotted on a nitrocellulose 
membrane (Schleicher & Schuell).  After blotting, the membrane was cut into stripes 
each containing a set of dilutions of hIL-13 and BSA. Blot stripes were blocked with 
TBST + 5% milk and each incubated with one of the purified scFv fragments at a 
concentration of 3.0 μM or with a rabbit polyclonal anti-hIL-13 (Abcam) (diluted 1: 
2000) as a positive control. All the following incubation and washing steps with the 
different membrane slices were performed with identical volumes, concentrations and 
time periods. Bound antibody fragments were detected by using a secondary mouse 
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anti-His6 antibody (1:500) and a tertiary goat anti-mouse IgG antibody conjugated to 
HRP (Santa Cruz Biotechnology) (1:4000), the positive control antibody was detected 
with a secondary anti-rabbit IgG HRP conjugated antibody (SIGMA) (1:400). 
Visualisation occurred with SuperSignalR West Pico Chemiluminescent Substrate 
(PIERCE) and x-ray films (Kodak). Antibodies were diluted to appropriate 
concentrations in TBST containing 0.5% milk. 
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3. 2. 4. Results 
In vivo screening of single-chain antibody fragments binding to human IL-13 
The SCINEX-P system allows detection of interactions among extracellular proteins 
occurring in the topologically extracellular lumen of the endoplasmic reticulum (ER) 
1
. This system exploits the properties of the type I ER resident protein Ire1p, which 
acts as a sensor of unfolded protein (UP) stress in yeast. UP-induced dimerization of 
Ire1p activates a signalling cascade to the nucleus via expression of the transcriptional 
activator Hac1p. Hac1p activates transcription of UP stress genes, thereby conferring 
tolerance to stress conditions such as elevated temperature. Moreover, via largely 
unknown pathways, Hac1p is also required for inositol synthesis. In an IRE1-deficient 
yeast strain we stably integrated a synthetic bi-directional promoter containing one or 
three tandem copies of the Hac1p binding site, the unfolded protein response element 
(UPRE) from the KAR2 promoter 35, controlling expression of divergently oriented 
lacZ and HIS3 reporter genes. Integration of these reporter genes resulted in the 
reporter strains IKU1-3 and IKU3-3, respectively. In this system the proteins of 
interest are fused to the reciprocally complementing mutant derivatives of Ire1p, 
Ire1Δtail495-982 29 (extending from aa residue 495 to 982) and Ire1K702R526-1115 30 (aa 
526 to 1115) so as to substitute for the Ire1p lumenal domain (Figure 1A). 
Dimerization of two interacting partners in the lumen of the ER allows interaction of 
the complementing Ire1p moieties and activation of UPR signalling. In IKU1-3 and 
IKU3-3, UPR signalling confers increased tolerance to elevated temperatures, induced 
inositol synthesis and activation of reporter gene expression, thus allowing growth 
under three independent selective conditions: i) histidine depletion (the stringency of 
this selective pressure can be modulated by the addition of the competitive inhibitor 
of the HIS3 gene product, 3-amino 1, 2, 4-triazol (3AT)), ii) Inositol depletion and iii) 
exposure to elevated temperatures (37°C) to which Δire1 cells are sensitive. In 
addition UPR signalling strength can be indirectly quantified by measuring activity of 
the β-Galactosidase expressed from the lacZ reporter gene.  
As a model system to establish screening procedures we have used mature 
hIL-13 consisting of residues 35 to 146 (hIL-1335-146).  hIL-1335-146 was fused between 
the SUC2 signal sequence (S2ss) and Ire1Δtail495-982 resulting in the antigen-construct 
(Figure 1B). This construct was expressed from an ARS/CEN URA3 plasmid under the 
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control of the constitutive ACT1 gene promoter. The scFv library was cloned between 
the S2ss and the mutant Ire1p derivative Ire1K702R526-1115 (Figure 1. B). In this 
primary scFv-library , 7 residues of the complementarity-determining region 3 of the 
heavy chain (CDRH3) in an scFv framework of the type Vλ3-VH1 termed FW7.3 
were randomised. This framework has been selected from a human scFv framework 
library to be especially stable even in a reducing environment 32. This library was 
expressed from an ARS/CEN LEU2 plasmid under the control of the very weak 
constitutive IRE1 gene promoter (PIRE1). 
Determination of screening conditions 
The aim of this primary screening was to isolate binders from an initial scFv library, 
while the aim of the affinity maturation was to monitor feasibility of selecting for 
increased binding activity by adjusting the selective conditions.(see below). In order 
to find the optimal conditions we transformed the reporter strains IKU1-3 and IKU3-3 
with empty vector (Figure 2a), library (b), library and antigen together (c) as well as a 
control construct expressed from the weak PIRE1 and consisting of the GCN4 leucine 
zipper (GCN4LZ), a homo-dimerization domain fused to the Ire1K702R526-1115. 
GCN4LZ induced homo-dimerisation of this mutant derivative of Ire1p that still bears 
a residual activity, and hence induces a relatively weak UPR signal (d). This construct 
was chosen as positive control since its moderate signalling activity might more 
closely represent the signalling activity of a low affinity scFv fragment expected to be 
selected in a primary screening. The transformed cells were then incubated at either 
30°C or 37°C for four days on synthetic complete medium selective for the 
transformed plasmids and containing the following modifications, each challenging 
different combinations of the three read-out systems outlined above and indicated in 
Figure 2: Depletion of inositol and incubation at non-permissive 37°C, selecting for 
Inositol synthesis and temperature tolerance (w); depletion of Inositol and addition of 
30mM 3AT, selecting for Inositol synthesis and HIS3 reporter gene activation (x); 
addition of 30mM 3AT and incubation at 37°C selecting for HIS3 reporter gene 
activity and for temperature tolerance (y); and Inositol depletion, addition of 30mM 
3AT and incubation at 37°C, selecting for all three read-out systems at once (z). For 
transformation and growth control, unmodified plates were incubated at the 
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permissive temperature of 30°C. Optimal conditions were found to be SC-U/L/H 
lacking Inositol and containing 30mM 3AT together with incubation at permissive 
temperature. With this combination of selective conditions, reasonable transformation 
efficiencies were obtained (d/x) whereas only very few background colonies appeared 
after four days (c/x). In contrast, all other conditions in which either inositol depletion 
or addition of 30mM 3AT was combined with direct incubation at 37°C, lowered 
transformation efficiency about ten fold without significantly improving the positive-
to-background ratio. No significant difference in terms of selectivity was observed 
between the two reporter strains IKU1-3 and IKU3-3. Level of expression of the lacZ
reporter gene as determined by measuring β-Galactosidase activity was generally 15-
20 fold higher with the strain IKU3-3 compared to IKU1-3, facilitating detection of 
weakly induced reporter gene expression. 
Primary screening of the scFv-H3 library 
IKU3-3 cells expressing the hIL-13 antigen construct were transformed with the 
primary scFv-library. We obtained an estimated number of about 1.5 x 106 colony-
forming units (cfu), which were screened on selective plates lacking uracil, leucine, 
histidine and inositol and containing 30mM 3AT incubated at 30°C. After two days 
incubation about 650 colonies appeared. In addition to these fast growing colonies we 
observed a higher number of smaller background colonies. In order to suppress such 
background, we shifted the plates from 30°C to a 37°C incubator. At the non-
permissive temperature, the 650 fast growing colonies continued to grow, whereas 
background colonies stopped growing. After day four 170 colonies were randomly 
picked and re-streaked on selective plates. 168 out of 170 re-streaked clones grew 
again on selective plates at 37°C; 26 colonies (~16%) showed an antigen dependent 
phenotype, since they no longer expressed the lacZ reporter gene upon loss of the 
URA3 bait plasmid on plates containing 5-fluoro-orotic acid (5FOA).  
 In order to confirm antigen-dependent and antigen-specific activation of the 
reporter genes, library-plasmids were isolated and re-transformed into cells expressing 
hIL-13 or an unrelated antigen, each fused to Ire1Δtail495-982. Among the 9 antigen-
specific clones, two were identical (only one of them (S1-18) is presented in Figure 
3). Cells co-expressing the scFvs S1-5, S1-18, S1-24 and S1-26 with hIL-13 showed a 
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strong blue staining on X-Gal plates indicating high lacZ expression. In contrast co-
expression of these clones with unrelated antigen did not significantly activate lacZ 
reporter gene expression, thus suggesting specific binding to hIL-13. The original 
framework 7.3 did not induce lacZ expression neither in the presence of hIL-13 nor in 
the presence of the unrelated antigen (Figure 3). Sequence analysis of the CDRH3 
revealed an enrichment of cysteine-containing CDRs. Out of the nine sequenced 
clones, six (2/3) contained a cysteine residue in the CDRH3 (Figure 3), which is 
significantly more than the theoretical probability of 7/32 (codon frequency). One 
clone was identical to the clone S1-18 (not shown in Figure 3). One possible 
explanation for the prevalence of cysteines might be the formation of covalent 
disulfide bonds between one of the five cysteines in IL-13 and a co-expressed scFv 
containing cysteines in its CDRH3. Covalent linkage of the antibody to its epitope 
would lead to maximal UPR signalling. However, none of the binders identified in 
this primary screening and containing cysteine residues in the CDRH3 reached the 
reporter gene activity of a very strong scFv – epitope interaction such as that between 
the well described αGCN4 scFv and its epitope, the leucine zipper of GCN4 (data not 
shown). This may argue against a covalent linkage, it remains however a possibility 
that the covalent linkage occurs between a very low number of molecules. 
In vivo affinity maturation of primary binders by homologous recombination 
In order to improve in vivo binding activity of the clones resulting from the primary 
screening, four amino acids in the complementarity-determining region 3 of the light 
chain (CDRL3) were randomised. Since the cysteine residues in the CDRH3 of the 
clones S1-24 and S1-26 are highly disadvantageous for purification and further in 
vitro characterization, the affinity maturation step was performed only with the clones 
S1-5 and S1-18, which do not contain cysteine residues in their CDRH3 (Figure 3). 
We therefore replaced the CDRL3 of the clones S1-5 and S1-18 with random amino 
acid sequences by homologous recombination in vivo (Schärer-Brodbeck C. & 
Barberis A. unpublished results) (Figure 1B). For this purpose we removed the 
original CDRL3 by restriction digestion. A donor DNA fragment bearing the 
randomised CDRL3 was produced by PCR using pDU162 as a template and a 3’ 
primer containing the randomised sequence. The resulting PCR product started 42 bp 
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upstream and 42 bp downstream of the CDRL3 thus providing homologies for 
recombination and also spanning the randomised CDRL3 that had been removed in 
the target vector.  The appropriate yeast strain was transformed with the linearised 
vector together with the double-stranded donor DNA fragments. Homologous 
recombination of the DNA fragment with the opened vector led to an scFv fragment 
containing the randomised CDRL3. The resulting libraries with a theoretical 
complexity of 160’000 different amino acid sequences were then subjected to a 
secondary screening under more stringent conditions than those of the primary 
screening. The transformed yeast cells were plated as in the primary screening on SC-
U/L/H plates lacking inositol and containing 30mM 3AT. To select for binders with a 
higher affinity to the target protein than the primary binders, the stringency of the 
selective condition was increased by incubating the plates directly at 37°C, after a 
short recovery phase of 2 hours at 30°C following transformation. Under these 
conditions, the original binders S1-5 and S1-18 did no longer form colonies even after 
a long incubation time (data not shown). 
 Transformations of the libraries based on S1-5 and S1-18 into IKU3-3 resulted 
in ~880’000 and ~1’040’000 transformed yeast cells screened on selective plates, 
respectively. Of the approximately 500 colonies of each library that appeared after 
four days, a total number of 256 colonies were randomly picked and re-streaked on 
selective plates and incubated at 37°C. Out of the 201 colonies that grew again, 19 
clones (~9.5%) showed antigen dependence upon loss of plasmid on 5-FOA plate. 
These 19 clones were further analysed by measuring activity of the lacZ reporter gene 
product in liquid after plasmid isolation and retransformation (Figure 4A). Most of the 
selected clones showed higher or similar lacZ reporter gene activity than the initial 
binder S1-18 (Figure 4A). The clones S2-13, S2-14, resulting from maturation of S1-
5, and clone S2-24 derived from S1-18, stimulated lacZ reporter gene activity to more 
than 3-fold higher levels than the level reached with the S1-18. These β-Galactosidase 
values aligned with the growth coefficients of the respective clones determined in 
liquid cultures on screening conditions (data not shown), thus confirming that growth 
depends on reporter gene activity. The Ire1p derivative Ire1K702R526-1115, to which 
the scFv-libraries were fused, bears residual signalling potential to about 40% of the 
wild-type Ire1p upon formation of Ire1K702R526-1115 homodimers.  CDRs comprising 
homo-dimerization activity would thus lead to increased UPR signalling and, 
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consequently, stronger reporter gene activation giving rise to a growth advantage that 
would not necessarily depend on binding affinity to the target protein. This possibility 
was examined by expressing the strongest activators from the affinity maturation 
screening S2-13, S2-14 and S2-24 as well as an intermediate activator S2-22 together 
with the IL-13 antigen construct or without in the IKU3-3 reporter strain (Figure 4B). 
While all binders activated lacZ reporter gene expression when co-expressed together 
with hIL-13 as epitope, none of them exhibited any detectable signal when co-
transformed with an empty vector. We therefore conclude that no significant homo-
dimerization of this scFv fragment occurs in the SCINEX-P system. It is worth noting 
that, contrary to what we observed with the selected CDRH3 sequences described 
above, none of the affinity-matured binders contained any cysteine residue in the 
CDRL3. 
Selected clones specifically bind to hIL-13 in vitro 
The 19 clones obtained by the screening experiments described above display a 
certain potential to bind hIL-13 in the context of the SCINEX-P system. Whether this 
in vivo performance is in accordance with their ability to bind hIL-13 as an epitope in 
vitro was investigated with purified proteins. The scFv sequences of the original 
framework 7.3, the binders from the primary screening S1-5 and S1-18 as well as the 
affinity matured S2-13, S2-14, S2-22 and S2-24 were sub-cloned into bacterial 
expression vectors providing a His6 tag at the C-terminus of the protein. The scFv 
antibodies were expressed in E. coli and purified from extracts by IMAC. Purified 
scFv fragments were examined for their ability to bind to recombinant human IL-13 
in ELISA. scFv fragments were added in a concentration of 5, 10 and 25 μM to 96 
well plates coated with hIL-13. Bound scFv fragments were detected by a secondary 
anti-His6 antibody, which in turn was detected by a tertiary horseradish peroxidase 
(HRP) conjugated antibody.  Amounts of scFv fragments bound to hIL-13 were 
quantified by measuring HRP activity. In a preliminary ELISA all the binders 
delivered by the SCINEX-P system gave a signal clearly above background and three 
out of four binders deriving from the affinity maturation step resulted in a 2 to 3 fold 
higher signal compared with the primary binders (data not shown). The hIL-13 – 
binding activities of the scFv fragments S1-18, S2-22 and S2-24 were analysed at 
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various scFv concentrations (Figure 5). All three scFv antibodies specifically bound to 
hIL-13 in a concentration dependent manner and scFv fragment S2-24 derived from 
scFv S1-18 showed an increased signal compared to its precursor S1-18. None of the 
binders tested reached clear-cut signal saturation at the concentrations tested, 
indicating a rather low affinity interaction with the recombinant hIL-13 in this ELISA 
experiment. Nevertheless the data indicate improvement in affinity of S2-24 and to a 
lower extend S2-22 due to their lower ratio in signal intensity between the tested scFv 
concentrations, compared to S1-18. These data are in agreement with the ability, of 
the respective clones, to induce lacZ reporter gene expression (Figure 4B). 
The ability of different scFv fragments to specifically bind hIL-13 was further 
examined by immunoblotting (Figure 6A). 4.5, 45 and 450 ng recombinant human IL-
13 as well as 450 ng BSA for control were separated on a SDS-15% poly acryl amid 
gel and electroblotted. The filters were incubated with purified scFvs. As expected, 
the framework 7.3 did not bind to hIL-13, whereas a faint signal was detectable with 
the primary binder S1-18 (Figure 6 A) staining the 450 ng band of hIL-13. The 
affinity-matured binder S2-24 showed a clearly improved sensitivity compared to the 
primary binder. Indeed, the matured binder S2-24 was able to detect 45 ng of 
recombinant hIL-13 on a western blot (Figure 6 B). None of the binders tested in this 
experiment bound to BSA, thus indicating specific recognition of hIL-13. These 
results demonstrate that in vitro binding activities of purified scFv proteins as 
determined in ELISA and western blotting correlate with relative lacZ expression and 
growth rate of cells expressing the respective scFv antibody fragments in the context 
of the SCINEX-P system.  
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3. 2. 5. Discussion
 Selecting scFv fragments binding to hIL-13 
In our previous work 1 we have shown that interactions between extracellular proteins 
can be detected with the SCINEX-P system in vivo and that cells expressing 
interacting proteins can be selected by growth. In the present study, an scFv antibody 
library of low complexity containing seven randomised amino acids in the CDR3 of 
the heavy chain was screened for binders against human IL-13 using the SCINEX-P 
growth selection system. Binders identified in the primary screening were 
subsequently randomised again within a four amino acid sequence of the light chain 
CDR3. By increasing the stringency of the selective pressure on growth, we selected 
from the second randomised scFv pool those clones showing improved in vivo
binding performance as well as improved in vitro properties, when compared to their 
precursors. We showed that cell growth and lacZ reporter gene activity correlate with 
the relative epitope binding strength of the various scFv clones in vitro. This is of 
great importance for an early discrimination between clones passing the bait-
dependence test, those that have predictable higher affinities for their antigen.  
Advantages of the system 
In vivo detection of interactions in a topologically extracellular environment such as 
the ER permits expression of extracellular or transmembrane proteins that would be 
incorrectly folded or unstable if expressed in the reducing environment of the 
cytoplasm or the of nucleus. Other methods such as phage-display or ribosomal-
display, in which oxidizing conditions can be mimicked, depend on purified proteins; 
purification of correctly folded proteins, especially in the case of multispanning 
transmembrane proteins, can be extremely difficult. Since only the cytoplasmic 
portion of Ire1p is necessary to detect dimerization 1, the mutant complementing 
moieties of Ire1p could be fused to the C-terminus of such full-length multispanning 
transmembrane proteins in order to detect interactions with other extracellular or 
intracellular proteins. In contrast to laborious in vitro assays the genetic system 
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presented here can be readily established in any molecular biology / genetic 
laboratory. 
Limitations of the system 
Due to the relatively low complexity of the scFv libraries screened in this study (1.5 x 
106 in the primary screening and about 160’000 in the affinity maturation screening), 
we apparently selected rather low affinity binders. The lower transformation 
efficiency of yeast compared to bacteria limits the maximal complexity to be screened 
in one step. We could show however that the system allows stepwise improvement of 
scFv binders by adjusting the selective pressure. Additional randomisations of other 
CDRs in the clones obtained in our screenings, in combination with further increased 
selectivity of the growth conditions, thus might lead to higher affinity antibodies. It is 
plausible that for example lower expression of the epitope would decrease signalling 
strength and thus disable growth of low affinity binders under similar conditions as 
those used in the preceding screening without lowering transformation efficiency.  
Further applications of the SCINEX-P system 
Complexities of eukaryotic cDNA libraries are far below the complexities described 
above for antibody libraries. Thus, SCINEX-P could be used to identify secreted or 
membrane attached proteins interacting with each other. Identification of orphan 
ligands binding to known cell surface receptors or vice versa is an important task in 
finding biological therapeutics to human disease. Expression of a soluble ligand into 
the secretory pathway where it meets its cognate receptor chains each fused to a 
complementing Ire1p derivatives would lead to ligand-induced receptor dimerization 
and thus to UPR signalling and growth under selective conditions. In such a set up, it 
would not be necessary to fuse the soluble ligand to an effector protein. Since Ire1p 
resides in the ER membrane, thus being restricted to a closed compartment, only cells 
expressing the soluble ligand but not cells in their neighbourhood would profit from a 
productive interaction. 
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3. 2. 7. Figures and Figure legends 
Figure 1: The principle of SCINEX-P. A) The proteins of interest are expressed as 
fusions to either one of the two Ire1p complementing mutant derivatives, Ire1Δtail or 
Ire1K70R. Upon interaction of dimerization partners, in the case depicted in this 
figure, antigen and a single-chain antibody fragment (scFv), the mutant Ire1p moieties 
come into close proximity allowing complementation and UPR signalling. Subsequent 
Hac1p production activates the three independently selectable read-outs: i) HIS3/lacZ
reporter gene expression, ii) inositol synthesis and iii) suppression of the temperature 
sensitive phenotype of Δire1 cells. B) In the construct expressed in this study, the 
Ire1p derivatives provide the transmembrane domain (TM). As antigen the mature 
human IL-13 extending from amino acid residue 35 to 146 was fused between the 
signal sequence of the SUC2 gene (Ss) and Ire1Δtail495-982. The scFv libraries were 
expressed as fusions of an N-terminal SUC2 signal sequence and the C-terminal 
Ire1K702R526-1115. In the primary scFv library 7 amino acids in the complementarity-
determining region of the heavy chain (CDRH3) were randomised. In the secondary 
scFv library used for affinity maturation, the light chain CDR3 (CDRL3), bearing 4 
randomised amino acids, was brought in by homologous recombination of a donor 
DNA with the vector in vivo. The donor DNA was spanning the CDRL3 and 42 bp 
flanking sequence containing homology to the vector. The original CDRL3 was 
deleted in the selected binders deriving from the primary screening by restriction 
digestion prior to homologous recombination.  
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Figure 2: Comparison of different read-out combinations. The Δire1 reporter 
strains IKU1-3 and IKU3-3 were transformed with a) empty vectors, b) library plus 
empty vector c) library plus antigen (hIL-13) and d) a positive control leading to a 
moderate UPR signalling and thus mimicking a low affinity interaction between 
antigen and antibody. Transformations were plated on synthetic complete (SC) media 
selective for the plasmid markers and modified as follows to challenge different 
combinations of the three SCINEX-P read-out systems; v) no modification as growth 
control, w) lacking inositol and incubation at non-permissive temperature (37°C), 
selecting for inositol synthesis and temperature tolerance, x) lacking inositol and 
containing 30 mM of 3-amino 1, 2, 4-triazole (3AT), selecting for inositol synthesis 
and HIS3 reporter gene activity, y) containing 30 mM 3AT and incubation at non-
permissive temperature, selecting for HIS3 reporter gene activity and temperature 
tolerance and z) a combination of all three read-outs. On SC medium lacking inositol 
and containing 30 mM 3AT good transformation efficiency (x/d) and only faint 
background growth (x/c) was observed. 
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Figure 2 
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Figure 3: Bait-specificity and bait-dependence of primary binders. Plasmids of 
screening positives from the primary screening were isolated and retransformed in 
IKU3-3 cells co-expressing hIL-13, an unrelated bait or an empty vector. Bait 
dependant lacZ reporter gene expression was monitored by X-gal filter lifts. All the 
scFv fragments examined in this assay showed a bait-dependant and bait-specific blue 
staining on X-Gal plates. The original framework 7.3 did neither bind to hIL-13 nor to 
an unrelated epitope. Amino acid sequences in the heavy chain CDR3 of the 
respective binders are indicated in single letter code. Residues randomised in the 
primary library are highlighted in grey; cysteine residues are depicted in bold letters. 
Clones S1-5 and S1-18 do not contain cysteines in the CDRH3 sequence and thus 
were carried on to affinity maturation (asterisks).
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Figure 4: Increased reporter gene activation of clones deriving from secondary 
screening. Plasmids of positives in the secondary screening were isolated and 
retransformed into IKU3-3 cells. LacZ reporter gene activity was determined by 
measuring enzymatic activity of β-Galactosidase, the lacZ gene product. A) scFv 
fragments S2-3 to S2-16 derive from S1-5 whereas scFv S2-17 to S2-27 are 
descending from S1-18. Most of the hIL-13 binders obtained in the second growth 
selection upon randomisation of the CDRL3 activated lacZ reporter gene expression 
to an elevated extent compared to the initial binder S1-18 when co-expressed with the 
hIL-13 antigen. B) The scFv fragments S1-18, S2-13, S2-14, S2-22, S2-24 strongly 
induce lacZ reporter gene expression when co-transformed with hIL-13 but do not if 
co-transformed with an empty vector (vec.). Neither the antigen fused to Ire1Δtail495-
982
, nor any of the scFv fragments fused to Ire1K702R526-1115 showed any reporter 
gene activation by itself. Amino acid sequences in the light chain CDR3 of the 
respective scFv fragments are indicated. 
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Figure 5: Antigen recognition of purified scFv fragments in ELISA. The scFv 
fragments S1-18 and derivatives thereof S2-22 and S2-24 were expressed in E.coli
and purified by IMAC. Qualitative binding properties of the purified scFv fragments 
were analysed in ELISA. Purified scFvs were added in different concentrations to 
either uncoated wells or to wells coated with 2.5 ug/ml recombinant hIL-13. S1-18, 
S2-22 and S2-24 bound to hIL-13 in an antigen- and scFv-concentration dependant 
manner. The signal of the scFv fragment S2-24 at 10 μΜ concentration was about 3 
fold stronger than the one of its precursor S1-18. 
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Figure 6: Antigen recognition of purified scFv fragments in western blot. 4.5, 45 
and 450 ng of recombinant hIL-13 and 450 ng of BSA were separated on a SDS-15% 
polyacrylamid gel and electroblotted on a nitrocellulose membrane. Blots were 
incubated with either purified scFv fragments at a concentration of 3.0 μM or with a 
polyclonal anti-hIL-13 antibody as a control. Bound scFv fragments were detected via 
their C-terminal His6-tag. A) While the original framework 7.3 did not exhibit any 
binding activity to hIL-13 the primary screening positive S1-18 weakly stained the 
450 ng hIL-13 band. The improved S2-24 showed a clearly enhanced signal compared 
to S1-18. B) With optimised washing and incubation periods S2-24 detected 45 ng of 
recombinant hIL-13. 
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3. 3. Part III 
3. 3. 1. Counter selection in the SCINEX-P system 
The identification of novel protein – protein interactions is an important step in the 
process of characterisation of a gene product function and its potential implications in 
disease. Once identified, disease-relevant protein interactions are promising targets 
for therapy by antibodies or small molecules that are able to break such contacts. So-
called counter selection genetic systems can be used to screen gene and compound 
libraries for identifying molecules that specifically block a certain protein pairing. In 
contrast to the classical yeast two-hybrid system, in which a protein interaction causes 
transcriptional activation of a reporter gene that confers a growth advantage to the 
respective cell, in counter selection systems expression of reporter genes inhibits 
growth, thus allowing positive selection screening for factors or substances that 
disrupt a certain protein interaction and block transcriptional activation. In addition, 
negative selection systems can be used to identify loss of function mutations that 
impair binding to the target protein. Sequence analysis of such mutants can reveal 
limiting residues involved in a certain protein interaction and thus enable 
characterisation of specific protein pair domains. In contrast to genetic systems, 
biochemical methods such as phage-display and ribosomal-display cannot readily be 
used for the identification of loss of function mutations.  
A GAL1-counter selectable read-out system has been developed in the 
laboratories of ESBATech. We have applied this counter selection system in the 
context of SCINEX-P in order to extend its application for the screening of peptides 
or small molecules that display an inhibitory effect towards certain extracellular 
protein – protein ligations, or for loss of function mutations. Several yeast toxic 
markers have been used for negative selection, most notably the URA3 and CYH2 1,2. 
For negative selection both of these markers need addition of compounds that are 
either toxic (CYH2) or that are metabolised into a toxic substance by the reporter gene 
product (URA3). In small-molecule screenings however, it is not desirable to have 
reactive substances in the screening medium that might interfere with library 
molecules. For this reason, we employed genetic components involved in yeast
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 galactose metabolism to establish a counter selectable read-out in the SCINEX-P 
system.    
The GAL2 gene encodes galactose permease, which imports galactose into the 
cell. Intracellular galactose is a substrate of galactokinase (Gal1p), which converts 
galactose to galactose-1-phosphate (gal-1-P). In wild type cells Gal7p and Gal10p are 
involved in further metabolisation of galactose-1-phosphate into glucose-1-phosphate 
3
. In GAL7 knockout cells gal-1-P metabolisation is abolished and gal-1-P 
accumulates to levels that are toxic to yeast cells. Such cells not only cannot use 
galactose as a carbon source, but also are unable to grow in presence of other sugars 
added to galactose because of accumulation of toxic gal-1-P 4 (Fig 1A). Genes 
involved in galactose metabolisation (gal-operon) in yeast are controlled by glucose- 
and galactose-dependent transcriptional regulators. Gal4p is a galactose dependent 
transcriptional activator controlling expression of the GAL genes 5,6. By knocking out 
the GAL4 gene, its endogenous target genes GAL1, GAL7 and GAL10 are no longer 
expressed and consequently functionally knocked out as well. In Δgal4 cells the 
GAL1 open reading frame can thus be used to generate a reporter gene for counter 
selection on galactose containing media, since toxic galactose-1-phosphate 
accumulates in these cells upon expression of Gal1p (Gunde et al manuscript in 
preparation).  
We stably integrated a synthetic bi-directional promoter containing the Hac1p 
binding sequence (UPRE) controlling the divergently oriented reporter genes lacZ and 
GAL1, at the URA3 locus of a GAL4 knockout strain (JPY-9). In this reporter strain, 
interactions of proteins fused to Ire1p C-terminal domains, through the UPR 
signalling cascade, would induce lacZ/GAL1 reporter gene expression (Fig 1B) and 
result in growth inhibition on galactose. Two resulting reporter strain clones JUGal1-1 
and JUGal1-2 were then transformed with empty vector or pDU44 7, an ARS/CEN
plasmid expressing a constitutively active JunLZ-Ire1p fusion protein from the ACT1
gene promoter. Transformants were plated on glucose and on galactose plates. JunLZ 
dimerisation caused activation of the Ire1p C-terminal domains and resulted in 
expression of the UPRE-lacZ/GAL1 reporter genes. As depicted in Figure 1C, UPRE-
lacZ expression levels of the two clones were inversely proportional to their ability to 
grow on plates containing galactose. High levels of reporter gene expression in 
JUGal1-1 even resulted in a complete deficiency to grow on galactose. Thus, this 
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system represents a means to screen for inhibitors of extracellular protein – protein 
interactions and may be amenable to high-throughput screenings of small molecule 
libraries on robotics platforms by using growth in liquid medium as read-out.   
  
  
3. 3. 2. A second pathway to sense accumulation of unfolded proteins in the ER  
Expression of soluble ligands  
We have shown that extracellular protein interactions can be detected in a two-hybrid 
approach using the SCINEX-P technology 7 (and chapter 3. 3. of this thesis). 
Nevertheless, in a two-hybrid set-up the proteins of interest are forced into a certain 
orientation by the C-terminally-fused transmembrane portion of Ire1p, which might 
be disadvantageous for the detection of interactions comprising soluble factors such 
as ligands. Many hormone proteins, for example, bind in a multimer conformation to 
their cognate receptors. Multimer formation of some ligands may be hindered by the 
conformational constraints of a two-hybrid set-up. In contrast, co-expression of 
receptor chains fused to Ire1p derivatives together with soluble ligands directed to the 
secretory pathway would theoretically allow detection of receptor chain clustering 
upon ligand binding in the SCINEX-P system (Fig 2). Moreover, exclusive detection 
of interactions in the ER, and not on the cell surface, would restrict the resulting 
growth advantage to cells expressing a cognate ligand, thus making the system 
adequate for genetic screenings to identify novel soluble factors. We therefore 
attempted to use SCINEX-P to study interactions of the soluble murine ligands mEGF 
and mVEGF with their receptors mEGFR and mFLT1, respectively.  
Soluble ligands in SCINEX-P induce UPR signalling in an unspecific manner. 
The extracellular domains of mEGFR and mFLT1 were fused between the N-terminal 
signal sequence of the SUC2 gene (S2ss) and a wild type C-terminal portion of Ire1p 
extending from amino acid residue 495 to 1115. Ligands were directed to the ER by 
fusing the sequences coding for the mature proteins between S2ss and an ER retention 
signal (HDEL). These constructs were expressed from ARS/CEN plasmids under the 
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control of the ACT1 gene promoter in the UPR reporter strain IKU1-3, as shown in 
Figure 2A. Expression of ligands alone did not result in a detectable reporter gene 
activity. The mFLT1-Ire1p fusion weakly induced UPRE-lacZ reporter gene 
activation, whereas mEGFR fusions strongly induced UPR signalling on its own. This 
may be in line with the finding that EGFR exists as a homodimer in the membrane 
already prior to ligand binding 8. A certain background activity of receptors fused to 
wild type Ire1p domains was expected since rare events of random receptor chain 
conjunctions are likely to occur in the two-dimensional space of the ER membrane. 
UPR signalling activity of both receptors was further inducible by co-expression of 
ligands. But unexpectedly both ligands enhanced the ability of both receptor 
constructs to induce lacZ expression.  mEGF as well as mVEGF induced UPR 
signalling activity if co-epressed with either the mEGFR- or the mFLT1-Ire1p fusion 
to the same extend in a receptor type unspecific manner (Fig 2A). One plausible 
explanation is that over-expression of the receptor constructs might result in 
unselective aggregates of receptor and ligands, thus inducing UPR signalling. In order 
to lower expression level and background activity, the wild type Ire1p moiety in the 
mEGFR constructs was exchanged by either one of the two complementing Ire1p 
derivatives Ire1K702R495-1115 and Ire1Δtail495-982. These new constructs were 
expressed from a very weak, galactose-inducible promoter containing only the fourth 
UASG from the GAL1/10 promoter. Although background-signalling activity of 
mEGFR was strongly reduced with these constructs, both ligands still activated 
reporter gene expression unspecifically. mVEGF  showed even a stronger potential to 
induce mEGFR dimerization than did mEGF (Fig 2B). Kaufman et al. 9 found that 
replacement of the Ire1p lumenal domain by the c-Jun leucine zipper (JunLZ) 
constitutively activated UPR signalling. These constitutively active Ire1p derivatives 
were, however, still inducible upon addition of the UPR inducing agent tunicamycin, 
indicating that not only the Ire1p lumenal domain senses accumulation of unfolded 
proteins. It might therefore be that the mammalian ligands mEGF and mVEGF 
accumulate in the ER lumen as unfolded proteins and induce UPR signalling through 
the residual Ire1p moieties comprising its cytoplasmic part and its transmembrane 
domain. 
 In order to elucidate whether the observations described above are artifacts of 
soluble ligand expression and whether the respective receptors and ligands are 
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functional in yeast, we expressed receptor – ligand pairs in the membrane two-hybrid 
approach of SCINEX-P (Fig 2C).  
Both mEGF and mVEGF bind to their receptors as homo-dimers. We thus 
excluded UPR induction due to ligand dimerisation by fusing the ligands between 
S2ss and the C-terminally deleted Ire1Δtail495-982 that does not exhibit residual 
signalling activity upon homo-dimerisation. The extracellular domains of the 
receptors were fused between S2ss and the kinase mutant Ire1K702R495-111. These 
constructs were expressed from ARS/CEN plasmid driven by the ACT1 gene promoter 
except for the mEGFR-Ire1p fusion, which was expressed from the weak, truncated 
ADH1 gene promoter, in order to lower the high background activity of this construct 
in SCINEX-P. In this setting both ligands, mEGF and mVEGF showed receptor 
specific reporter gene activation. As an additional control, the totally unrelated 
extracellular domain of Ost1p fused to Ire1Δtail495-982 did not induce UPR signalling 
above background levels if co-expressed with both receptor constructs (Fig 2C). 
 These data clearly show that cell surface receptors and their ligands can be 
functionally expressed in yeast when expressed as membrane attached fusion proteins 
in a two-hybrid set-up. In contrast, soluble expression of mEGF and mVEGF in the 
ER may induce unfolded protein response through the residual Ire1p portion in a 
receptor-independent manner. 
Sensing accumulation of unfolded proteins in the ER lumen in the absence of 
transmembrane Ire1p. 
 In order to test the hypothesis outlined above, namely that over-expression of 
ligands in the yeast ER might induce unfolded protein response, mVEGF and its 
receptor mFLT1 were examined for their potential to induce UPR signalling in an 
IRE1 wild type strain. While the receptor construct and mVEGF fused to Ire1Δtail495-
982
 did not significantly induce UPR signalling above the activities reached in a Δire1
strain, soluble mVEGF indeed activated UPRE-lacZ reporter gene expression to 
almost 30% of the value reached by co-expression of receptor and ligand in the same 
strain (data not shown). Expression of soluble mVEGF may thus induce unfolded 
protein stress in the yeast ER, which, through Ire1p derivatives, is signalled to the 
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nucleus and may thus be the cause for unspecific reporter gene activity previously 
reported.  
To confirm this assumption we expressed three constructs containing the 
JunLZ as a dimerisation domain followed by different portions of wild type Ire1p (as 
depicted in Figure 4A) that resulted in i) a transmembrane protein (S-JunLZ-Ire1495-
1115), ii) a fusion protein anchored in the membrane by a myristoyl residue attached to 
an N-terminal myristoylation box (M) (M-JunLZ-Ire1ΔTM555-1115) or iii) solubly 
expressed in the cytosol (JunLZ-Ire1ΔTM555-1115). Localisation of the two cytoplasmic 
constructs by fluorescence microscopy showed that M-JunLZ-Ire1ΔTM555-1115 clearly 
localises to the plasma membrane, whereas JunLZ-Ire1ΔTM555-1115 showed a dotted 
pattern all over the cell (Fig 3A), which we could not assigne to a certain cell 
compartment (Fig 3B). Most importantly both cytoplasmic Ire1p fusion proteins did 
not specifically stain the ER indicating that they are most probably uncoupled from 
the ER lumen. All three constructs, which are expected to constitutively form dimers 
due to the JunLZ moiety, spontaneously activated UPRE-lacZ reporter gene 
expression. Surprisingly, all of them where further inducible by tunicamycin 
treatment by about a factor 1.5 – 2 (Fig 4B). Tunicamycin inhibits N-linked 
glycosylation of secretory proteins and thus causes accumulation of unfolded proteins 
in the ER, which is sensed in the wild type yeast by full-length Ire1p.  
Induction of UPR signalling by tunicamycin in the presence of the 
transmembrane Ire1p derivative could be explained by the residual 30 amino acids of 
the Ire1p lumenal domain, which might still sense accumulation of unfolded proteins. 
The two cytoplasmic Ire1ΔTM constructs, in contrast, cannot directly communicate 
with the ER lumen. Signal transduction from the ER lumen to the cytosol must 
therefore occur via an alternative pathway. In an attempt to define the step in which a 
putative second UPR pathway discharges into the Ire1p/Hac1p signalling cascade, we 
ectopically expressed a spliced version of the HAC1 open reading frame from an 
ARS/CEN plasmid under the control of the ACT1 promoter in Δhac1 cells. 
Constitutive expression of Hac1p resulted in constitutive UPR signalling, which was 
only slightly, if at all, inducible by tunicamycin treatment (Fig 4C). Co-expression of 
S-JunLZ-Ire1495-1115, the constitutively active transmembrane Ire1p construct, showed 
no effect in this Δhac1 strain indicating that active Ire1p does not influence Hac1p 
activity at the protein level.  
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Our observations that a) constitutively active cytosolic Ire1p fusions are 
further inducible by generation of stressful conditions in the ER lumen and b) that the 
reporter gene activity upon constitutive expression of Hac1p is not significantly 
inducible by such conditions, suggest an enhancement of processes between Ire1p 
activation and Hac1p translation by a redundant pathway transmitting a signal from 
the ER lumen to the cytosol. The activity of the ACT1 gene promoter did not 
significantly increase upon tunicamycin treatment as determined by measuring β-
galactosidase expression from a PACT1-lacZ vector, excluding the possibility that 
simply expression of the Ire1p-fusion proteins was enhanced by tunicamycin (data not 
shown). Already in 1996 Shamu and Walter found that about one-third of the KAR2
promoter activation is independent of IRE1 10. A genome-wide analysis identified 87 
open reading frames (ORF) that are induced in response to ER stress in Δire1Δhac1
strains 11. Recently, Schroder et al. 12 found that the mediator complex member Sin4p 
is involved in IRE1/HAC1 independent UPR signalling. ER-stress inducing agents 
again activated UPRE-lacZ reporter gene expression in Δsin4Δire1Δhac1 cells, in 
contrast to Δire1Δhac1 cells. Moreover, activation of transcription was independent of 
UPREs in the reporter gene promoter. The authors called this effect core promoter 
activation (CPA), which was specific for a certain subset of genes whereof most were 
UPR targets. Schroder et al. claim that the very weak basal expression of UPR target 
genes is the reason why activation of these genes by UPR inducing agents was not 
detectable in Δhac1Δire1 SIN4 wild type cells. According to one model, SIN4
deletion increases basal transcription of these UPR target genes, and only upon 
increasing basal activity the effect on expression by an alternative UPR pathway is 
detectable. CPA contributed about 10% to the activation of the UPR target gene PDI1
and to even higher extend to induction of the UPRE-lacZ used in the Schroder study,
which consisted of the CYC1 core promoter (an UPR target gene) containing an 
inserted UPRE. Interestingly, not every UPR target gene was inducible by CPA. SCJ1
and EUG1 for example are not targets of core promoter activation upon ER stress. 
 The UPRE-lacZ reporter construct used in our study consisted of the GAL1
core promoter containing an inserted UPRE. GAL1 expression was not induced by 
tunicamycin neither in wild type nor in Δire1Δhac1 cells (Travers et al.) and is thus 
not a target of UPR or CPA. Consequently, CPA is rather unlike to explain a 1.5 – 2 
fold activation of our UPRE-lacZ reporter gene by tunicamycin, which we observed 
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in Δire1 cells expressing a constitutively active cytoplasmic Ire1p-construct. 
Furthermore, if HAC1/IRE1 independent pathways were responsible for additional 
transcriptional activity, we would expect equally strong core promoter activation 
independent of which factor in the UPR cascade is constitutively active. This 
expectation is in contrast to our findings that only the signal obtained from 
constitutive active Ire1p and not from Hac1p was further inducible. Our current data, 
however, cannot exclude that over-expression of Hac1p in our experiments 
overweighs the effect of an alternative pathway that activates reporter gene 
expression. Integration of the HAC1i open reading frame (ORF) into the HAC1 locus 
might help excluding artifacts resulting from over-expression. An alternative 
approach to investigate the endpoint of a putative second pathway is to determine the 
ratio of HAC1i mRNA versus HAC1u mRNA by RNA mapping analysis, in cells 
expressing constitutively active cytoplasmic Ire1p constructs in the presence and 
absence of tunicamycin. Assuming that the second UPR pathway activates 
transcription in an IRE1/HAC1 independent mechanism, HAC1u mRNA splicing 
should not be induced by tunicamycin in this set-up. 
3. 3. 3. Conclusions 
Expression of soluble ligands into the secretory pathway seems to induce UPRE-
reporter gene expression through an unknown pathway and moreover in a receptor 
independent manner. Our results obtained with the cytoplasmic Ire1p constructs 
indicate that a putative second pathway discharges into the known UPR cascade 
somewhere between Ire1p activation and Hac1p translation. The findings of Schroder 
et al. in contrast suggest a HAC1/IRE1 independent signalling that activates UPR 
target genes in a UPRE independent manner. Identification of members of this 
pathway would in any case provide information for a rational approach to circumvent 
an unspecific UPR signalling in order to afford detection of interactions between 
soluble ligands and their cell-surface receptors.  
Since the UPR target genes SCJ1 and EUG1 are not inducible by CPA their 
promoters could be utilised in reporter constructs instead of the artificial promoter 
used in this study, consisting of the GAL1/10 core promoter, containing inserted 
Screening for extracellular protein interactions in yeast Results, Part III 
82 
UPRE sequences. Application of SCJ1 and EUG1 promoters in SCINEX-P would 
possibly uncouple UPR from CPA and allow screenings for soluble ligands in Δire1
cells. 
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3. 3. 4. Materials and methods 
 Recombinant plasmids construction 
Expression vectors: extracellular domains of mouse EGFR, mFLT1 and the lignads 
mEGF and mVEGF where amplified by PCR from a mouse cDNA library. The PCR 
primers binding to the 5’ of the respective sequence contained an XbaI site followed 
by the SUC2 signal sequence (S2ss) flanking the homology region. The S2ss 
substituted for the mammalian secretion signal of the respective genes. All primers 
binding to the 3’ sequence of the gene of interest (GOI) used to generate fusions to the 
Ire1p C-termini, were flanked by a NotI restriction site allowing in-frame fusion to the 
Ire1p C-termini resulting in the junction GOI-ggc ggc cgc-IRE1 (NotI site bold). 3’ 
primers used to generate soluble ligands contained the sequence coding for the ER 
retention signal (HDEL) followed by a NotI site flanking the homology region. The 
JunLZ fragments containing an N-terminal S2ss and a C-terminal HA tag where 
amplified by PCR using pDU44 as template and a 3’ primer providing the HA tag and 
a flanking NotI site. Ire1 C-termini were amplified by PCR as described in 7. The 
genes of interest and IRE1 parts where cloned into the XbaI/SalI treated yeast 
expression vectors pDU10 (PACT1, ARS/CEN, LEU2), pDU12 (PACT1, ARS/CEN, 
TRP1) or pMH4 (PADH1, ARS/CEN, LEU2). Construction of these vectors as well as 
of pDU44 (PACT1, ARS/CEN, TRP1) expressing S-JunLZ-Ire1555-1115 was described 
elsewhere 7. The GAL1/10 promoter, deleted for UASG 1-3 was constructed by PCR 
amplification using a 5’ primer of the sequence 5’-
gaattccgtcctcgtcctcaccggtcg-3’ annealing upstream of UASG 4 and 
containing a flanking EcoRI site, and a 3’ primer of the sequence 5’-
gcgtctagagttttttctccttgacg-3’ annealing downstream of the TATA box 
and containing a flanking XbaI site. The resulting PCR product was cloned into 
EcoRI/XbaI treated pDU10. 
Integration vectors: The UPRE-Gal1-lacZ reporter plasmid pDU101 was 
constructed by substituting the six LexA binding sites in the bi-directional GAL1/10
promoter of pDE94-Gal1 by one UPRE from pPL1 by the use of unique BamHI and 
SalI restriction sites flanking the cis-activating sequences in both plasmids.  
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Yeast strains & media 
 The S. cerevisiae strain JUGal1 was generated by transformation of JPY-9 
(ura3-52; his3Δ200; leu2Δ1; trp1Δ63; lys2Δ385; gal4Δ11; MATα) with the reporter 
construct pDU101 carrying the divergently oriented lacZ and GAL1 reporter genes 
under the control of a bi-directional promoter containing one UPRE from the KAR2
promoter. The plasmid was linearised prior to transformation at the BstBI site in the 
URA3 gene. Growth on uracil lacking plates selected for stable integration in the 
URA3 locus, which was confirmed by PCR analysis. Generation of the s. cerevisiae
strain IKU1-3 was described elsewhere 7. HAC1 knockouts were done in the UPRE 
reporter strain YPL-2 7 by replacing the HAC1 ORF by the selectable marker 
kanMX4.
 Yeast genetics and media were as described 13. For selection of plasmids, 
dropout media containing all except the specified amino acid were used. Yeast 
transformation was performed by the lithium acetate procedure 14. Tunicamycin was 
added to a final concentration of 1mg ml-1 to liquid cultures 3 hours prior to 
determination of β-galactosidase activity. Counter selection on plates: JUGal1 clones 
were transformed with indicated plasmids and cells were plated on selective plates 
containing 2% glucose or 3% galactose, 2% raffinose and 2% glycerol instead of 
glucose. Cultures were incubated at 30°C.  
Assay of cellular β-Galactosidase activity 
 
β-Galactosidase activity of cells was determined using the protocol described in 13. 
Activity was normalised to the number of cells assayed.  
Immunostainings 
The protocol used for immunolocalisation of cytoplasmic Ire1p fusion proteins was 
performed as described 15. The monoclonal mouse anti-HA antibody (SIGMA) was 
used as a primary antibody in a working dilution of 1:50 in PEMBAL. The secondary 
antibody against mouse IgG was coupled to the fluorophor Cy3 (Jackson 
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ImmunoResearch Laboratories Inc.) and diluted 1:500 in PEMBAL. Fluorescence 
was observed with a 100-x objective on a Leica microscope (Leica DM R). Exposure 
parameters were adjusted to signal strength. For staining of nuclear DNA with DAPI 
(4,6-diamidino-2-phenylindol), the fixed, spheroblasted, and permeabilised yest cells 
were incubated with 1 microgram/ml DAPI in 100% ethanol for 1 minute followed by 
extensive washing with 1xPBS. 
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3. 3. 5. Figures and Figure legends 
Figure 1. The GAL1 counter selectable read-out in the SCINEX-P system. A) The 
GAL2 gene product promotes internalisation of extracellular galactose (gal). Inside 
the cell galactose is converted to galactose-1-phosphate (gal-1-P) by the GAL1 gene 
product the galactokinase. The GAL7 gene product (uridylkinase) catalyses 
production of glucose-1-Phosphate (glu-1-P) and UDP-galactose. UDP-galactose is 
recycled to UDP-glucose (UDP-glu) by the GAL10 gene product (in grey). Mutants 
lacking GAL7 activity accumulate gal-1-phosphate, which in high levels is toxic to 
yeast cells. B) Homo-dimer formation of c-Jun leucine zippers (JunLZ) brings the C-
terminally fused Ire1p moieties into close proximity allowing auto-phosphorylation 
and subsequently, through Hac1p, activate transcription of the UPRE-GAL1-lacZ
reporter genes. In presence of galactose, expression of the GAL1 gene product leads to 
accumulation of toxic gal-1-P, which inhibits growth. C) Counter selection on 
galactose: JUGal1-1 and JUGal1-2 cells were transformed with either a vector 
expressing the constitutively active Ire1p fusion protein (S-JunLZ-Ire1p) or an empty 
vector. JUGal1-1 cells strongly express the UPRE-GAL1-lacZ reporter genes, as 
determined by measuring β-galactosidase activity, and do thus not grow on glucose 
containing medium. JUGal1-2 cells express the reporter genes to a lower extend than 
JUGal1-1 cells and consequently exhibit a milder phenotype on galactose. 
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Figure 2. Co-expression of receptors and ligands in SCINEX-P. UPR signalling 
activity was quantified by measuring β-galactosidase activity in transformed IKU1-3 
cells in liquid cultures. A) Co-expression of receptor extracellular domains (RECD) of 
mEGFR and mFLT1with their solubly expressed ligands mEGF and mVEGF, 
respectively. All constructs were expressed from the ACT1 gene promoter (PACT1). 
Receptors were fused to wild type C-terminal domains of Ire1p (Ire1p526-1115). B)
RECD of mEGFR was expressed as fusion to either one of the two complementing 
mutant derivatives of Ire1p (Ire1K702R526-1116) and Ire1Δtail526-982) under the control 
of the truncated GAL1/10 promoter (PGAL1(4)) in galactose containing medium. C)
Expression of RECD of mEGFR and mFLT1 together mEGF, mVEGF and the 
extracellular domain of Ost1 in the two-hybrid set-up of SCINEX-P. mEGFR was 
expressed from the truncated ADH1 promoter (PADH1). 
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Figure 3. Immunostaining of cytoplasmic Ire1p fusion proteins. IKU1-3 cells 
were transformed with the plasmids expressing M-JunLZ-Ire1ΔTM555-1115 or JunLZ-
Ire1ΔTM555-1115 or with an empty vector. A) Localisation of the fusion proteins was 
determined by fluorescence microscopy using a primary antibody directed against the 
HA-tag in the respective constructs. B) Staining of JunLZ-Ire1ΔTM555-1115 using the 
anti HA antibody, and DAPI staining of the nucleus.  
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Figure 3 
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Figure 4. Sensing accumulation of unfolded proteins through an IRE1-
independent mechanism. A) Schematic drawing of the Ire1p fusion proteins 
expressed in IKU1-3 cells (shown in B and C). SUC2 signal sequence (S2ss), 
myristoylation box (M), leucine zipper of c-Jun (JunLZ), mammalian hemagglutin tag 
(HA), C-terminal domain of Ire1p extending from amino acid 495 to 1115 (Ire1p495-
1115), C-terminal domain of Ire1p lacking its transmembrane domain and extending 
from residue 555 to 1115 (Ire1ΔTM555-1115). All constructs were expressed from the 
ACT1 gene promoter. B) β-galactosidase reporter gene activity obtained upon 
expression of constitutively active Ire1p fusion proteins in the Δire1 strain IKU1-3 
before and 3 hours after addition of 1mg ml-1 tunicamycin to the medium. C) β-
galactosidase reporter gene activity upon expression of the spliced HAC1 ORF under 
the control of the ACT1 promoter with and without co-expression of a constitutively 
active Ire1p fusion protein in a Δhac1 UPRE reporter strain. Signals were measured 
before and 3 hours after addition of 1mg ml-1 tunicamycin to the medium. 
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4. GENERAL CONCLUSIONS 
Interactions among extracellular and transmembrane proteins regulate a variety of 
important physiological processes and are involved in a multitude of diseases. A 
detailed understanding of the interaction network among extracellular and cell surface 
proteins would allow us to gain insight into complex physiological processes and 
would probably facilitate rational approaches to therapy. Recent attempts to map the 
entire interactome of a given organism by use of the classical yeast two-hybrid 
method have shown that this method is biased to intracellular protein interactions 
(reviewed by 1). Of the 8988 known human genes in the ENSEMBL database 
containing a SWISSPROT ID, 2331 (25.9%) contain a signal sequence, and 2391 
(26.6%) contain a transmembrane domain. Taking in account that only 14.1% bear 
both, a signal sequence as well as a transmembrane domain leads to the assumption 
that almost 40% of the known genes in the ENSEMBL database code for secreted or 
transmembrane proteins. Equal numbers were obtained by screening other human 
protein databases for these two features. It remains yet unclear whether these data are 
representative for the entire human genome. Many of the putatively 
extracellular/transmembrane proteins are still not assigned to a certain function. For 
example in a recently published high throughput attempt to identify novel human 
secreted and transmembrane proteins, in which bio-informatic and genetic methods 
have been combined, a total of 1047 cDNA clones have been identified, 256 of which 
were novel genes of unknown function 2. Though, the identification of binding 
partners of secreted and transmembrane proteins is complicated by their biochemical 
properties.  
The problems arising with transmembrane proteins regarding attempts to 
identify and characterise interaction partners can be exemplified by G protein coupled 
receptors (GPCRs), which represent a pharmacologically important class of 
transmembrane proteins. At present 39 of the top 100 marketed drugs in use directly 
or indirectly act through activation or blockade of GPCR-mediated receptors. Nearly 
160 GPCRs have been identified based on their gene sequence and their ability to 
interact with known endogenous ligands. However, an estimated 500-800 additional 
GPCRs have been classified as "orphan" receptors (oGPCRs) because their 
endogenous ligands have not yet been identified 3. Ligands that bind to disease 
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relevant oGPCRs or agents that block the interactions between a certain ligand and its 
receptor may be used for therapy. GPCRs are difficult to purify in high amounts and 
to keep functional after solubilisation and purification. Thus biochemical methods for 
the identification of peptides or molecules that interact with GPCRs in high 
throughput approaches are rather inappropriate. For this class of proteins also 
conventional genetic systems to detect protein interactions, such as nuclear or 
cytoplasmic yeast two-hybrid methods are inapplicable since transmembrane proteins 
are unlike to fold properly if expressed in the cytoplasm, and their hydrophobic 
transmembrane domains tend to aggregate in an aqueous environment. It exists 
therefore a great need for genetic systems that are compatible with the requirements 
of extracellular and transmembrane proteins, and which are amenable for large-scale 
screenigs. However, among the genetic systems able to detect interactions between 
membrane-attached proteins (such as DHFR complementation, β-galactosidase 
complementation, G-protein fusions and the split-ubiquitin system as reviewed by 
Stagljar and Fields 1), to our knowledge none has been successfully used to date for 
the identification of extracellular interaction partners. Although we did not 
demonstrate the feasibility of SCINEX-P for multispanning transmembrane proteins, 
we believe that extracellular interactions comprising GPCRs can be reconstituted in 
this system. This assumption is supported by the fact that the mammalian oGPCR 
FPRL-1 was functional when expressed as a fusion protein in yeast 4. 
4. 1. Monitoring extracellular protein interactions in SCINEX-P 
In part 3. 1. of this work we demonstrate the feasibility of SCINEX-P to detect protein 
interactions occurring in the topologically extracellular compartment of the ER. We 
used the leucine zipper of GCN4 (GCN4LZ), which contains dimerization activity, as 
an epitope, and various single-chain antibody fragments (scFvs) to demonstrate the 
ability of the SCINEX-P system to specifically detect protein – protein interactions in 
the lumen of the ER. In this set-up the epitope was expressed as a fusion to Ire1Δtail 
in order to prevent UPR induction due to GCN4LZ homo-dimerization. Antibody 
fragments where fused to Ire1K702R. Co-expression of the epitope construct together 
with the GCN4LZ specific scFvs λ-graft or α-GCN4wt resulted in reconstitution of 
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UPR signalling, while co-expression of the epitope with the non-binder AL-5 did not. 
In contrast to the very stable λ-graft α-GCN4wt was not functional if expressed in the 
reducing environment of the cytosol 5, where disulfide-bonds cannot form. In the 
SCINEX-P system, however, reporter gene activity obtained by co-expressing the 
GCN4LZ epitope with α-GCN4wt was as high as that observed with the even 
intracellularly stable λ-graft, indicating that extracellular proteins are properly folded 
in SCINEX-P. Mutating the cysteine residues in α-GCN4wt (α-GCN4(SS--)) resulted 
in a loss of in vivo binding activity in SCINEX-P. α-GCN4(SS--) did no longer 
induce UPR signalling above background level, thus underlining the importance of 
disulfide bond formation for functionality. UPRE-lacZ reporter gene activity 
correlated with growth on selective plates, thus Δire cells expressing a pair of 
interacting extracellular proteins could be selected by growth on medias challenging 
different read-out systems (inositol depletion, histidine depletion and exposure to 
elevated temperature). By assessing combinations of different selective pressures the 
stringency of growth selection could be modified. In addition, we showed that the 
Ire1p cytotplasmic portion, lacking both the N-terminal lumenal domain as well as the 
transmembrane domain, is sufficient for UPR induction and can thus be fused to the 
C-term of full-length transmembrane proteins for identifying extracellular and 
intracellular interaction partners.  
4. 2. Screening for extracellular protein interactions in SCINEX-P 
In 3. 2. the SCINEX-P system was then applied to screen a scFv fragment library for 
binders to the cytokine interleukin-13 (IL-13). Both, IL-13 as well as scFv fragments 
are extracellular proteins containing disulfide-bonds, which are essential for proper 
folding. The scFv library was based on a framework of the Vλ3-VH1 type containing 
seven randomised amino acid residues in the complementarity-determining region 3 
of the heavy chain. Binders obtained in a primary screening where randomised in four 
amino acid residues of their complementarity-determining region 3 in the light chain 
by homologous recombination in yeast and subjected to a second screening under 
higher selective conditions. Positives from this second affinity maturation screening 
with improved in vivo binding activity were purified and further analysed in vitro. The 
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results obtained from Western blot experiments and from ELISA indicate that the 
scFv fragments deriving from the affinity maturation screening indeed exhibit a 
higher affinity to their epitope then the original binders resulting from the primary 
screening. Thus growth behaviour and reporter gene expression were in good 
correlation with in vitro results, demonstrating the feasibility of SCINEX-P for 
genomic screenings to identify extracellular protein – protein interactions. We could, 
however, not reproduce the interactions between hIL-13 and the scFv fragments 
obtained from the SCINEX-P screenings in a classical nuclear yeast two-hybrid 
approach (data not shown). This indicates that either hIL-13 or the scFv fragments (or 
both) are not functional if expressed in the cytoplasm, underlining the importance of 
extracellular protein interactions to be reconstituted in a cognate environment. 
4. 3. Outlook 
In both the primary screening and the affinity maturation screening we encountered a 
relatively high number of false positives, 84% and 90%, respectively, which activated 
the UPRE-lacZ reporter gene in a bait-independent manner. The presence of scFv 
fragments possessing homo-dimerisation activity, which consequently activate the C-
terminally fused kinase mutant derivative of Ire1p (Ire1K702R), is the most probable 
explanation for bait-independent UPR signalling. Such bait-independent clones could 
readily be sorted out, since they did no longer stain blue on X-Gal plates upon loss of 
the URA3-bait-plasmid on 5FOA plates. Nevertheless, in cDNA screenings, clones 
exhibiting dimerisation activity are not necessarily false positives, since they might 
still interact with the bait protein. It would therefore be more convenient to exclude 
false positives that do not interact with the bait from the beginning. This could be 
achieved by expressing the library as a fusion to the Ire1Δtail mutant instead of 
Ire1K702R, since Ire1Δtail contains no residual UPR signalling potential and thus, in 
contrast to Ire1K702R, cannot be activated by homo-dimer formation. This approach, 
however, assumes that a particular bait protein, fused to Ire1K702R does not form 
dimers on its own.  
The ultimate solution to exclude false positives resulting from homo-
dimerisation, however, would be to use a mutant Ire1p derivative that bears no 
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residual signalling potential, but whose activity could still be complemented by the 
tail deletion mutant Ire1Δtail. Such kinase mutants, though, have not yet been 
identified. SCINEX-P could be employed to identify such Ire1p derivatives by 
screening for loss of function mutants in the UPR-counter selectable reporter strain 
JUGal1 (described in 3. 3) in a first round, and, in a second round selecting those 
among the pool of inactive mutants that can reconstitute UPR signalling if co-
expressed with the Ire1Δtail mutant. This second selection for the ability to 
complement Ire1Δtail could be performed in the UPR-positive selectable IKU3-3 
strain.
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5. APPENDIX 
5. 1. Genotypes of the strains 
Strain Genotype Reference 
W303-1A leu2-3,-112; his3-11,-15; trp1-1; ura3-1; ade2-1; can1-100; MATα R. Rothstein 
JPY-5 leu2Δ1; his3Δ200; trp1Δ63; ura3-52; lys2Δ385; MAT α (Barberis, Pearlbert et 
al. 1995) 
JPY-9 leu2Δ1; his3Δ200; trp1Δ63; ura3-52; lys2Δ385; MAT α; gal4Δ̧̧ (Barberis, Pearlbert et 
al. 1995) 
YPL-2 ura3-52; his3Δ200::HIS3+::1xUPRE::LacZ; leu2Δ1; trp1Δ63; 
lys2Δ385; gal4Δ11; MAT α
This study 
UPRE Δhac1 leu2-3,-112; his3-11,-15::HIS3+::1xUPRE::LacZ; trp1-1; ura3-1; 
ade2-1; can1-100; MATα; ̓Δhac1::kanMX4 
This study 
IKU1-3 leu2-3,-112; his3-11,-15::HIS3+::1xUPRE::LacZ; trp1-1; ura3-1; 
ade2-1; can1-100; MATa; Δire1::kanMX4 
This study 
IKU2-3 leu2-3,-112; his3-11,-15::HIS3+::2xUPRE::LacZ; trp1-1; ura3-1; 
ade2-1; can1-100; MATa; Δire1::kanMX4 
This study 
IKU3-3 leu2-3,-112; his3-11,-15::HIS3+::3xUPRE::LacZ; trp1-1; ura3-1; 
ade2-1; can1-100; MATa; Δire1::kanMX4 
This study 
DIKU1-5 leu2-3,-112; his3-11,-15::HIS3+::1xUPRE::LacZ; trp1-1; ura3-
1::URA3+::Δder1; ade2-1; can1-100; MATa; Δire1::kanMX4 
This study 
JUGal1-1/-2 gal4Δ11; leu2Δ1; his3Δ200; trp1Δ63; ura3-52::URA3+::lacZ-
1xUPRE-GAL1; lys2Δ385; MAT α; ̓Δire1::kanMX4 
This study 
5. 2. Yeast plasmids 
Vectors 
   
Plasmid Yeast ori Yeast marker Promoter Multiple cloning site 
pDU10 CEN4-ARS1 LEU2 ACT1 XbaI/XhoI/StuI/NotI/SalI 
pDU12 CEN4-ARS1 TRP1 ACT1 XbaI/XhoI/StuI/NotI/SalI 
pDU13 CEN4-ARS1 URA3 ACT1 XbaI/XhoI/StuI/NotI/SalI 
pMH4 CEN4-ARS1 LEU2 ADH1 XbaI/XhoI/StuI/NotI/SalI 
pMH7 CEN4-ARS1 LEU2 IRE1 XbaI/XhoI/StuI/NotI/SalI 
pMH28 CEN4-ARS1 TRP1 ADH1 XbaI/XhoI/StuI/NotI/SalI 
pMH30 CEN4-ARS1 TRP1 IRE1 XbaI/XhoI/StuI/NotI/SalI 
   
Expression plasmids   
Plasmid Yeast ori Yeast marker Promoter Insert 
pDU17 CEN4-ARS1 TRP1 ACT1 Ost1 ecd-Ire1Δtail495-1115
pDU22 CEN4-ARS1 LEU2 ACT1 S2ss-mFLT1 ecd-Ire1wt526-1115
pDU26 CEN4-ARS1 TRP1 ACT1 S2ss-Ire1wt526-1115
pDU32 CEN4-ARS1 LEU2 ACT1 Ost1 ecd-Ire1K702R495-1114
pDU33 CEN4-ARS1 TRP1 ACT1 S2ss-Ire1K702R495-1114
pDU34 CEN4-ARS1 LEU2 ACT1 S2ss-Ire1Δtail495-1115
pDU39 CEN4-ARS1 LEU2 ACT1 S2ss-JunLZ-re1K702R495-1114
pDU40 CEN4-ARS1 TRP1 ACT1 S2ss-JunLZ-Ire1Δtail495-1115
pDU42 CEN4-ARS1 LEU2 ACT1 S2ss-FosLZ-Ire1K702R495-1114
pDU44 CEN4-ARS1 TRP1 ACT1 S2ss-JunLZ-Ire1495-1115
pDU46 CEN4-ARS1 LEU2 ACT1 S2ss-JunLZ-Ire1495-1115
Screening for extracellular protein interactions in yeast Appendix 
103 
pDU51 CEN4-ARS1 TRP1 ACT1 M-JunLZΔTM-HA-Ire1wt555-1115
pDU53 CEN4-ARS1 TRP1 ACT1 JunLZΔTM-HA-Ire1wt555-1115
pDU60 CEN4-ARS1 TRP1 ACT1 S2ss-mEGFR ecd-Ire1wt526-1115
pDU69 CEN4-ARS1 TRP1 ACT1 S2ss-mEGFR ecd-Ire1Δtail526-982
pDU70 CEN4-ARS1 LEU2 ACT1 S2ss-mEGFR ecd-Ire1K702R526-1115
pDU71 CEN4-ARS1 LEU2 ACT1 S2ss-mFLT-1 ecd-Ire1Δtail526-1115
pDU72 CEN4-ARS1 TRP1 ACT1 S2ss-mEGF-Ire1Δtail495-1115
pDU73 CEN4-ARS1 TRP1 ACT1 S2ss-mVEGF-Ire1Δtail495-1115
pDU78 CEN4-ARS1 LEU2 ACT1 S2ss-mFLT-1 ecd-Ire1K702R526-1115
pDU89 CEN4-ARS1 TRP1 ACT1 Ost1 ecd-Ire1Δtail526-1115
pDU100 CEN4-ARS1 LEU2 ADH1 trunc. S2ss-mEGFR ecd-Ire1K702R526-1115
pDU106 CEN4-ARS1 TRP1 ACT1 S2ss-GCN4LZ-Ire1Δtail495-980
pDU120 CEN4-ARS1 TRP1 ADH1 trunc. S2ss-GCN4LZ-Ire1Δtail495-980
pDu121 CEN4-ARS1 LEU2 ADH1 trunc. S2ss-GCN4LZ-Ire1K702R495-1114
pDU126 CEN4-ARS1 LEU2 ADH1 trunc. S2ss-λ-Graft-Ire1K702R525-1115
pDU148 CEN4-ARS1 TRP1 IRE1 S2ss-GCN4LZ-Ire1Δtail495-980
pDU149 CEN4-ARS1 LEU2 IRE1 S2ss-λ-Graft-Ire1K702R525-1115
pDU150 CEN4-ARS1 LEU2 IRE1 S2ss-AL-5-Ire1K702R525-1115
pDU152 CEN4-ARS1 LEU2 IRE1 S2ss-α-GCN4(SS--)-Ire1K702R526-1115
pDU153 CEN4-ARS1 LEU2 IRE1 S2ss-α-GCN4wt-Ire1K702R526-1115
pDU155 CEN4-ARS1 LEU2 IRE1 S2ss-κ-Graftt-Ire1K702R526-1115
pDU156 CEN4-ARS1 LEU2 ACT1 S2ss-mVEGF-HDEL 
pDU160 CEN4-ARS1 URA3 ACT1 S2ss-mVEGF-HDEL 
pDU161 CEN4-ARS1 URA3 ACT1 S2ss-mEGF-HDEL 
pDU162 CEN4-ARS1 LEU2 IRE1 S2ss-scFv 7.3-Ire1K702R526-1115
pDU172 CEN4-ARS1 URA3 ACT1 S2ss-hIL-13-Ire1Dtail495-980
pRL25 CEN4-ARS1 LEU2 IRE1 S2ss-GCN4LZ-Ire1K702R495-1114
pRL36 CEN4-ARS1 LEU2 GAL1(4) S2ss-mEGFR ecd-Ire1K702R526-1115
pRL37 CEN4-ARS1 TRP1 GAL1(4) S2ss-mEGFR ecd-Ire1Dtail526-982
   
Integration vectors   
  Integration site Promoter Reporter 
pDU101 URA3 locus GAL1/10::1xUPRE lacZ/GAL1 
pDU141 URA3 locus GAL1/10::1xUPRE lacZ/HIS3 
pDU142 URA3 locus GAL1/10::2xUPRE lacZ/HIS3 
pDU143 URA3 locus GAL1/10::3xUPRE lacZ/HIS3 
M = myristoylation signal; S2ss = SUC2 signal sequence; ADH trunc. = truncated ADH1 gene promoter; ecd = 
extracellular domain. 
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